≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Type1 diabetes, definitions combined, early onset

Endpoint Browser PheWeb

T1D_EARLY

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Pre-conditions: EVENT_AGE < 20

Registry filters:

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

3123

6. Filter based on genotype QC (FinnGen only)

3123

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF7

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 3123 1640 1483
Unadjusted period prevalence (%) 0.60 0.56 0.65
Median age at first event (years) 9.83 9.74 9.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3025
Matched controls
30084
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H3600, E103
ICD-10 Finland
NA
81.5
323.0
667
104
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
61.4
323.0
407
76
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
78.7
323.0
604
95
215
Kela drug reimbursment
Diabetes, non-insulin-treated
310.3
323.0
2844
1449
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
147.8
323.0
1481
194
H3601, E103
ICD-10 Finland
NA
52.5
323.0
427
94
A10AA02
ATC
NA
178.7
323.0
1673
207
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
129.7
323.0
614
59
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
201.6
323.0
1989
282
A10AE06
ATC
insulin degludec; parenteral
89.4
323.0
1226
228
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
103.7
323.0
806
105
177
Kela drug reimbursment
Insulin glargine 300 U / ml
55.0
323.0
572
127
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1108.8
323.0
2860
464
E10
ICD-10 Finland
Type 1 diabetes mellitus
111.1
323.0
1196
176
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
77.2
323.0
506
78
A10AA01
ATC
NA
183.3
323.0
1681
204
103
Kela drug reimbursment
Diabetes, insulin-treated
511.2
323.0
2915
1462
A10AE05
ATC
insulin detemir; parenteral
150.9
323.0
1937
350
T89
ICPC
Diabetes insulin dependent
204.1
323.0
2181
375
A10AE04
ATC
insulin glargine; parenteral
125.2
323.0
2169
594
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
12.7
323.0
1190
1459
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
82.6
323.0
825
136
XCK10
NOMESCO Finland
Photography of fundus of eye
40.6
323.0
1353
587
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
59.0
323.0
570
118
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
383.1
323.0
2329
263
H04AA01
ATC
glucagon; nasal, parenteral
293.5
323.0
2169
259
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
56.2
323.0
407
83
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
67.3
323.0
815
164
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
242.5
323.0
2472
542
H36.00
ICD-10 Finland
Diabetic background retinopathy
69.9
323.0
419
69
A10AA03
ATC
NA
65.7
323.0
392
68
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
70.7
323.0
735
136
Z01.0
ICD-10 Finland
Examination of eyes and vision
10.3
323.0
1390
2302
SPAT1262
SPAT
Handing over of treatment supplies
21.5
323.0
1567
1432
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
238.8
323.0
2435
513
CKC12
NOMESCO Finland
Photocoagulation of retina
28.1
323.0
517
219
H3603, E103
ICD-10 Finland
NA
44.2
323.0
416
108
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
144.6
323.0
1730
274
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
51.6
251.2
304
65
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.9
229.7
572
863
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
38.1
229.2
295
85
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
75.3
225.7
257
37
SPAT1008
SPAT
Photography of fundus of the eye or interpretation of photograph
26.2
222.1
315
133
C10AA05
ATC
atorvastatin; oral
5.5
213.3
713
1584
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
9.4
213.2
472
583
H36.01
ICD-10 Finland
Diabetic maculopathy
43.3
198.1
248
62
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
11.2
198.0
393
394
C10AA01
ATC
simvastatin; oral
5.8
189.7
598
1222
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
36.4
182.4
237
70
C09AA02
ATC
enalapril; systemic
7.0
178.8
479
786
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
29.3
178.7
245
90
A10AB06
ATC
insulin glulisine; parenteral
50.8
176.4
214
45
MAA00
NOMESCO Finland
Amniocentesis
13.6
171.8
309
249
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
71.3
169.9
195
29
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
72.2
166.7
191
28
T90
ICPC
Diabetes non-insulin dependent
5.5
161.0
527
1110
C10AA07
ATC
rosuvastatin; oral
5.5
160.5
523
1096
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
24.6
156.2
225
98
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
18.6
155.0
245
142
171
Kela drug reimbursment
Degludekinsuliini
89.6
152.6
170
20
M65.3
ICD-10 Finland
Trigger finger
13.3
148.4
269
219
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
21.8
138.6
207
101
H43.1
ICD-10 Finland
Vitreous haemorrhage
20.7
133.7
203
104
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
10.9
130.1
260
258
Z96.4
ICD-10 Finland
Presence of endocrine implants
70.9
124.6
143
21
C09AA05
ATC
ramipril; oral
5.2
123.7
422
915
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
34.9
122.2
160
48
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
63.4
119.9
140
23
H3602, E103
ICD-10 Finland
NA
42.0
112.2
141
35
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
6.1
108.1
317
570
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
5.5
107.8
345
690
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.2
99.8
164
5792
E10.01
ICD-10 Finland
Insulin-dependent diabetes diabetic coma with hyperglycemia
60.2
94.4
111
19
WZC30
NOMESCO Finland
Teaching
3.9
94.3
434
1245
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
55.0
93.9
112
21
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
67.5
90.9
105
16
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
35.9
90.9
118
34
RD210
NOMESCO Finland
NA
6.6
88.5
239
383
CKC10
NOMESCO Finland
Local photocoagulation of retina
21.7
87.4
130
62
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.8
85.4
396
1138
6480A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus
71.0
84.6
97
14
OAB50
SPAT
NA
22.8
81.3
119
54
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
10.2
81.2
166
170
CKC15
NOMESCO Finland
Panretinal photocoagulation
27.6
79.5
110
41
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
10.2
74.5
152
155
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
7.8
73.8
177
238
CK2S4
SPAT
NA
38.8
71.5
91
24
E16.0
ICD-10 Finland
Drug-induced hypoglycaemia without coma
89.7
71.1
79
9
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.7
70.9
340
998
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.4
70.6
374
1189
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.8
69.9
509
2016
CL2S4
SPAT
NA
38.1
64.2
82
22
XCD10
NOMESCO Finland
Electrophysiological examination of eye
9.7
64.1
134
143
E10.09
ICD-10 Finland
Insulin-dependent diabetes mellitus - With coma
54.6
63.0
75
14
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.2
63.0
92
3552
H03AA01
ATC
levothyroxine sodium; systemic
2.5
62.9
563
2503
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
6.3
62.5
174
289
ACC51
NOMESCO Finland
Release of median nerve
4.6
62.4
232
538
371
Kela drug reimbursment
Degludekinsuliini
85.2
60.0
67
8
TQB05
NOMESCO Finland
Puncture of skin of trunk
17.8
59.4
94
54
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.9
58.9
259
703
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
55.8
96
3408
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
55.9
55.7
66
12
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
285.1
55.3
56
*
R4190
NOMESCO Finland
Nutritional therapy
3.8
54.4
249
698
C10AX09
ATC
ezetimibe; oral
5.3
54.1
172
336
ZXA10
NOMESCO Finland
Bilateral
2.5
53.8
493
2202
I10
ICD-10 Finland
Essential (primary) hypertension
2.2
53.4
616
3082
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
31.4
53.3
71
23
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
98.0
52.9
58
6
F43
ICPC
Eye, Other diagnostic procedure
13.5
51.1
90
68
K90.0
ICD-10 Finland
Coeliac disease
5.0
50.5
170
354
NBT60
NOMESCO Finland
Forcible manipulation of humeroscapular joint
17.9
50.2
79
45
XCH00
NOMESCO Finland
Eye pressure measurement
7.3
49.8
124
176
O82.0
ICD-10 Finland
Delivery by elective caesarean section
3.6
49.8
240
702
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
3.1
49.6
297
1022
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
49.5
701
3822
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
31.4
48.9
65
21
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
3.1
48.2
294
1022
205
Kela drug reimbursment
Chronic hypertension
3.4
47.7
246
759
N01BB20
ATC
amides - combinations; parenteral
6.9
46.6
120
179
Z45.1
ICD-10 Finland
Adjustment and management of infusion pump
55.7
46.5
55
10
SPAT1325
SPAT
Vaccination
1.9
46.4
891
5438
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
37.4
46.2
59
16
T89
ICD-10 Finland
NA
75.3
46.0
52
7
SPAT1359
SPAT
Use of symptom diary
6.4
45.4
123
197
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
18.9
44.8
69
37
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
+∞
44.8
43
*
T69
ICPC
Metabolic, Other reason for encounter NEC
40.5
44.7
56
14
XCK20
NOMESCO Finland
NA
118.7
43.7
47
*
CKD40
NOMESCO Finland
Endophotocoagulation of retina
15.1
43.6
73
49
H36.02
ICD-10 Finland
Preproliferative diabetic retinopathy
24.3
42.2
60
25
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
11.9
41.4
77
66
XCD20
NOMESCO Finland
Photoangiography of eye
14.9
41.0
69
47
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
13.0
40.9
73
57
0088X
ICD-9 Finland
Intestinal infections due to other organisms, Other organism, not elsewhere classified
6.7
40.7
106
161
SPAT1054
SPAT
Examination of peripheral nervous system
12.8
40.1
72
57
2504B
ICD-9 Finland
Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]
75.8
39.9
45
6
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
21.8
39.5
58
27
E16.19
ICD-10 Finland
Other specified hypoglycaemia
21.8
39.5
58
27
T66
ICPC
Metabolic, Referral to non-MD provider
52.7
39.5
47
9
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
4.7
38.3
135
296
RJ126
NOMESCO Finland
NA
36.5
36.8
47
13
CJB10
NOMESCO Finland
Laser discission of secondary cataract
9.3
36.6
77
84
T87
ICPC
Hypoglycaemia
22.3
36.5
53
24
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
9.4
36.3
76
82
C09BA02
ATC
enalapril and diuretics; systemic
6.1
36.3
102
172
104
Kela drug reimbursment
Thyroid insufficiency
3.8
36.2
161
439
T31
ICPC
Metabolic, Medical examin/health eval partial
15.7
35.9
59
38
RJ210
NOMESCO Finland
NA
27.5
35.8
49
18
25008
ICD-8 Finland
Diabetes mellitus, Complicatio alia definita
127.5
35.7
38
*
H02AB06
ATC
prednisolone; systemic
0.5
35.6
442
7314
T45
ICPC
Metabolic, Observ/health educat/advice/diet
14.5
35.4
60
42
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
4.6
34.8
126
284
MAX99
NOMESCO Finland
Assistance to normal delivery
0.3
34.3
85
2547
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.3
33.9
89
2596
WX140
NOMESCO Finland
Parabulbar anesthesy
8.2
33.8
77
96
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
9.7
33.6
69
72
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
9.5
33.6
70
75
Z96.1
ICD-10 Finland
Presence of intraocular lens
6.3
33.6
92
150
RJ420
NOMESCO Finland
NA
25.0
33.5
47
19
Z97.8
ICD-10 Finland
Presence of other specified devices
38.5
33.3
42
11
H25.1
ICD-10 Finland
Senile nuclear cataract
6.2
33.3
92
152
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
16.1
33.2
54
34
CK2K4
NOMESCO Finland
Red-free imaging of ocular fundus
33.3
33.0
43
13
H26.4
ICD-10 Finland
After-cataract
8.3
32.6
73
89
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
54.6
32.2
38
7
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.2
31.9
88
145
C09CA01
ATC
losartan; oral
2.4
31.9
282
1219
RJ410
NOMESCO Finland
NA
18.3
31.7
49
27
RJ411
NOMESCO Finland
NA
14.9
31.7
53
36
R4180
NOMESCO Finland
Podiatric therapy
13.3
30.8
54
41
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
17.3
30.5
48
28
W84
ICPC
Pregnancy high risk
2.6
30.0
227
897
2510B
ICD-9 Finland
Other disorders of pancreatic internal secretion, Hypoglycaemic coma[COMA HYPOGLYCAEMICUM]
58.6
30.0
35
6
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.4
30.0
150
451
E10.0
ICD-10 Finland
Type 1 diabetes mellitus, With coma
83.0
29.7
33
*
JLE03
NOMESCO Finland
Allogenic total transplantation of pancreas with pancreaticoenterostomy
37.2
29.2
37
10
C08CA01
ATC
amlodipine; oral
2.2
28.8
334
1640
M72.0
ICD-10 Finland
Palmar fascial fibromatosis [Dupuytren]
9.8
28.5
58
60
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.8
28.3
124
335
T48
ICPC
Metabolic, Clarification/discussion RFE/demand
20.6
27.7
41
20
2500B
ICD-10 Finland
NA
62.3
26.9
31
5
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
271.9
26.7
27
*
ZXA05
NOMESCO Finland
Left side
1.9
26.5
422
2345
C03CA01
ATC
furosemide; systemic
2.6
26.5
203
810
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
25.8
1119
8301
25007
ICD-8 Finland
Diabetes mellitus, Coma diabeticum
261.3
25.7
26
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.0
25.0
81
163
H26.2
ICD-10 Finland
Complicated cataract
10.5
24.7
48
46
RS221
NOMESCO Finland
NA
4.5
24.6
88
197
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
0.4
24.3
149
3112
M54.5
ICD-10 Finland
Low back pain
0.6
24.1
375
5946
0086X
ICD-9 Finland
Intestinal infections due to other organisms, Enteritis due to specified virus[ENTERITIS VIROSA NUD]
5.3
23.9
74
142
C08CA13
ATC
lercanidipine; oral
3.3
23.8
126
396
D06BB04
ATC
podophyllotoxin; topical
2.1
23.5
275
1352
R11
ICD-10 Finland
Nausea and vomiting
2.2
23.5
266
1290
L84
ICD-10 Finland
Corns and callosities
4.3
23.4
89
212
Z34
ICD-10 Finland
Supervision of normal pregnancy
0.2
23.3
23
1133
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
2.3
23.2
233
1067
O48
ICD-10 Finland
Prolonged pregnancy
0.0
23.2
*
637
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
23.1
459
2742
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.9
23.1
58
85
N0830, E102
ICD-10 Finland
NA
65.1
22.8
26
*
H16.0
ICD-10 Finland
Corneal ulcer
2.6
22.7
176
706
T30
ICPC
Metabolic, Medical examin/health eval complete
40.2
22.6
28
7
L92.1
ICD-10 Finland
Necrobiosis lipoidica, not elsewhere classified
25.9
22.6
31
12
H3603, E107
ICD-10 Finland
NA
32.3
22.3
29
9
O60
ICD-10 Finland
Preterm labour and delivery
3.0
22.0
131
447
ZXA00
NOMESCO Finland
Right side
1.8
21.9
437
2614
H3600, E109
ICD-10 Finland
NA
38.7
21.7
27
7
RD212
NOMESCO Finland
NA
220.3
21.6
22
*
C02EA02
ATC
NA
15.5
21.0
34
22
D06BB10
ATC
imiquimod; topical
2.6
20.9
155
605
J01DA01
ATC
[U] cefalexin; systemic
1.4
20.9
1537
12555
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.9
20.9
353
1998
QBA00
NOMESCO Finland
Puncture of skin of trunk
28.1
20.9
28
10
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
20.8
226
1072
B03XA02
ATC
darbepoetin alfa; parenteral
6.6
20.6
53
81
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
3.9
20.4
86
226
T62
ICPC
Metabolic, Administrative procedure
20.1
20.3
30
15
J02AC01
ATC
fluconazole; systemic
1.5
20.0
916
6781
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.9
20.0
125
441
5790A
ICD-9 Finland
Intestinal malabsorption, Coeliac disease
27.1
20.0
27
10
S01ED51
ATC
timolol, combinations; ophthalmic
4.3
19.7
74
175
H33.4
ICD-10 Finland
Traction detachment of retina
21.6
19.4
28
13
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
1.8
19.2
344
1985
SPAT1281
SPAT
Other administrative function
2.0
19.0
241
1224
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.6
19.0
41
48
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
18.2
19.0
29
16
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
19.0
442
2765
00920
ICD-8 Finland
Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)
2.9
18.9
119
422
Z13.5
ICD-10 Finland
Special screening examination for eye and ear disorders
12.7
18.8
33
26
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
3.5
18.7
88
254
Z94.0
ICD-10 Finland
Kidney transplant status
4.5
18.6
66
148
T43
ICPC
Metabolic, Other diagnostic procedure
38.4
18.5
23
6
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.5
17.9
143
583
137
Kela drug reimbursment
Uraemia requiring dialysis
6.3
17.8
47
75
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
7.3
17.6
42
58
RJ122
NOMESCO Finland
NA
36.7
17.6
22
6
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
17.5
227
1161
B01AC04
ATC
clopidogrel; oral
3.2
17.4
92
291
B07.9
ICD-10 Finland
Verruca simplex
2.5
17.4
140
575
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.4
17.3
85
255
QDH05
NOMESCO Finland
Correction of deformity of toe nail
9.8
17.1
34
35
WX882
NOMESCO Finland
High dependency care
2.6
17.0
125
489
Z49.0
ICD-10 Finland
Preparatory care for dialysis
8.0
16.9
38
48
RJ120
NOMESCO Finland
NA
25.6
16.8
23
9
QDH
NOMESCO Finland
Operations on toe nails
19.3
16.8
25
13
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
63.3
16.7
19
*
J01FF01
ATC
clindamycin; systemic
1.5
16.6
584
4050
M03BX02
ATC
tizanidine; oral
0.7
16.5
975
12038
2505B
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI I]
169.9
16.5
17
*
CKD50
NOMESCO Finland
Endodiathermy of retina
23.0
16.4
23
10
H25.8
ICD-10 Finland
Other senile cataract
8.4
16.1
35
42
B05DA
ATC
Isotonic solutions
6.5
16.0
41
63
G63.2
ICD-10 Finland
Diabetic polyneuropathy
24.5
15.9
22
9
V03AE01
ATC
polystyrene sulfonate; oral
7.7
15.8
36
47
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
4.3
15.8
58
136
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
6.3
15.7
41
65
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
3.8
15.7
66
175
H3603, E109
ICD-10 Finland
NA
26.3
15.5
21
8
N083, E102
ICD-10 Finland
NA
85.1
15.5
17
*
Y6099
ICD-8 Finland
Prenatal care and observation
6.2
15.4
41
67
WW200
NOMESCO Finland
Immunization
2.8
15.3
98
352
A11CC03
ATC
alfacalcidol; systemic
3.8
15.3
65
174
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.3
15.2
40
64
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
5.0
15.2
48
96
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
16.0
15.2
24
15
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
17.7
15.1
23
13
RJ521
NOMESCO Finland
NA
20.0
15.0
22
11
SPAT1263
SPAT
Sampling
1.4
15.0
1122
9001
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
0.2
14.9
11
651
NDM10
NOMESCO Finland
Palmar fasciotomy of hand
10.8
14.9
28
26
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.8
14.7
48
100
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
10.4
14.6
28
27
T60
ICPC
Metabolic, Result test/procedure
10.4
14.6
28
27
NBE15
NOMESCO Finland
Incision or suture of capsule of joint of shoulder, arthroscopic
18.4
14.6
22
12
XCK00
NOMESCO Finland
Perimetry
2.6
14.6
107
420
WX892
NOMESCO Finland
Monitored bed care
2.1
14.4
156
743
RD112
NOMESCO Finland
NA
8.9
14.4
30
34
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.8
14.3
60
159
-44
ICPC
Preventive immunization/medic
2.1
14.3
157
749
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
14.3
127
551
B05DB
ATC
Hypertonic solutions
6.9
14.3
35
51
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.4
14.2
61
1461
ZX198
NOMESCO Finland
Other local administration
6.3
14.2
37
59
W85
ICPC
Gestational diabetes
0.3
14.1
30
973
H40.0
ICD-10 Finland
Glaucoma suspect
2.8
14.1
91
330
RD120
NOMESCO Finland
NA
17.5
13.8
21
12
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
13.5
13.7
23
17
C02AC05
ATC
moxonidine; oral
4.3
13.5
49
114
A10AE01
ATC
insulin (human); parenteral (insulins and analog. for injection, long-acting)
+∞
13.5
13
*
XCW10
NOMESCO Finland
Assessment of vision
14.7
13.5
22
15
-39
ICPC
Physical function test
16.2
13.4
21
13
C01DA14
ATC
isosorbide mononitrate; oral
4.4
13.3
48
111
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.5
13.3
127
2321
8811
FHL
Cesarean section
3.1
13.3
72
234
-45
ICPC
Observ/health educat/advice/diet
2.7
13.3
88
326
O14.1
ICD-10 Finland
Severe pre-eclampsia
4.7
13.2
44
94
C10AA03
ATC
pravastatin; oral
4.0
13.2
52
131
RJ421
NOMESCO Finland
NA
12.1
13.0
23
19
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.9
13.0
42
87
0092A
ICD-9 Finland
Ill-defined intestinal infections, Infectious diarrhoea
3.6
13.0
58
163
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
22.5
12.8
18
8
A10BX01
ATC
guar gum; systemic
6.4
12.8
33
52
Z71.8
ICD-10 Finland
Other specified counselling
1.4
12.8
684
5138
WX320
NOMESCO Finland
Spinalanesthesy
1.6
12.8
353
2296
Z49.2
ICD-10 Finland
Other dialysis
5.6
12.8
36
64
A63.0
ICD-10 Finland
Anogenital (venereal) warts
1.9
12.7
188
1013
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
6.2
12.7
33
53
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
0.3
12.6
31
939
A12AA04
ATC
calcium carbonate; oral
4.2
12.5
46
109
TK800
NOMESCO Finland
Hemodialysis
3.6
12.5
55
153
S01EE01
ATC
latanoprost; ophthalmic
5.0
12.5
39
78
7870A
ICD-9 Finland
Symptoms involving digestive system, Nausea and vomiting
7.0
12.5
30
43
L03
ICPC
Low back symptom/complaint
0.6
12.5
274
4078
H360, E103
ICD-10 Finland
NA
129.8
12.4
13
*
RK621
NOMESCO Finland
NA
129.8
12.4
13
*
S97
ICPC
Chronic ulcer skin
3.0
12.3
71
240
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
6.8
12.3
30
44
CKD15
NOMESCO Finland
Injection of vitreous substitute
10.5
12.2
23
22
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.7
12.1
280
1740
C09AA04
ATC
perindopril; oral
3.7
12.1
51
137
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
21.2
12.0
17
8
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.4
11.9
39
1039
M54
ICD-10 Finland
Dorsalgia
0.5
11.9
99
1885
SPAT1229
SPAT
Assessment of need for aid
2.6
11.9
84
324
C07AA05
ATC
propranolol; systemic
0.6
11.9
227
3487
2510A
ICD-9 Finland
Other disorders of pancreatic internal secretion, Hypoglycaemic coma[HYPERINSULINAEMIA IATROGENEA SEU FACTITIA]
46.6
11.8
14
*
JLE70
NOMESCO Finland
Inspection and preparation of pancreas, pre-transplantation
46.6
11.8
14
*
N0832, E102
ICD-10 Finland
NA
46.6
11.8
14
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
11.8
171
917
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.8
11.7
73
261
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
0.2
11.7
10
536
A10BA02
ATC
metformin; oral
0.5
11.6
83
1659
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.4
11.6
57
1292
R56.8
ICD-10 Finland
Other and unspecified convulsions
1.9
11.6
176
957
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
5.0
11.5
36
73
J05AH02
ATC
oseltamivir; oral
5.0
11.5
36
73
2508B
ICD-9 Finland
Diabetes mellitus, Diabetes with other specified manifestations[DIABETES MELLITUS CUM COMPLICAT NON DESCR,TYP I]
+∞
11.4
11
*
J01EA01
ATC
trimethoprim; systemic
1.5
11.4
436
3060
RJ190
NOMESCO Finland
NA
13.6
11.4
19
14
Z02.4
ICD-10 Finland
Examination for driving licence
1.9
11.3
169
916
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.6
11.3
49
136
SPAT1373
SPAT
Combined screening in early pregnancy
0.1
11.2
5
418
2500X
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,NUD]
34.9
11.2
14
*
R03AC02
ATC
salbutamol; inhalant
0.8
11.2
987
11715
CA1ME
NOMESCO Finland
Ultrasound oculometry
8.9
11.2
23
26
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
9.6
11.2
22
23
RK111
NOMESCO Finland
NA
25.0
11.1
15
6
L08
ICPC
Shoulder symptom/complaint
1.6
11.0
300
1945
M54.4
ICD-10 Finland
Lumbago with sciatica
0.5
11.0
119
2104
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.4
11.0
39
90
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.0
10.9
*
267
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.6
10.9
277
1767
J01MA02
ATC
ciprofloxacin; systemic
1.4
10.8
630
4791
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
5.7
10.8
30
53
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
0.4
10.8
34
920
SPAT1010
SPAT
Ophthalmoscopy
11.9
10.8
19
16
2512X
ICD-9 Finland
Other disorders of pancreatic internal secretion, Hypoglycaemia, unspecified[HYPOGLYCAEMIA NUD]
28.0
10.7
14
5
C09AA01
ATC
captopril; oral
17.8
10.7
16
9
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.8
10.7
187
1068
AN1
HP
Coronary angiography
3.2
10.6
55
175
E66
ICD-10 Finland
Obesity
0.2
10.6
13
561
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
6.7
10.6
26
39
3620B
ICD-9 Finland
Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]
59.9
10.6
12
*
Z37.0
ICD-10 Finland
Single live birth
0.6
10.6
141
2357
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
3.6
10.6
46
128
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.3
10.5
94
412
N05AH03
ATC
olanzapine; systemic
0.4
10.5
59
1278
N05AH04
ATC
quetiapine; oral
0.6
10.4
245
3608
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
3.0
10.4
60
204
C10AA04
ATC
fluvastatin; oral
4.0
10.4
40
100
2502B
ICD-9 Finland
Diabetes mellitus, Diabetes with hyperosmolarity[COMA DIABETICUM ,TYYPPI I]
109.8
10.4
11
*
S20
ICPC
Corn/callosity
4.7
10.3
34
73
H28.0
ICD-10 Finland
Diabetic cataract
16.0
10.3
16
10
SPAT1380
SPAT
Postpartum check-up
0.6
10.3
196
3013
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
10.2
805
6422
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
0.4
10.2
38
959
127
Kela drug reimbursment
Transplant complication
2.9
10.2
60
209
E66.01
ICD-10 Finland
Obesity due to excess calories
0.5
10.1
65
1344
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
7.4
10.1
23
31
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.5
10.1
358
2469
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
3.0
10.1
58
197
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.0
9.9
*
241
O40
ICD-10 Finland
Polyhydramnios
3.3
9.8
48
147
A07EC02
ATC
mesalazine; oral, rectal
0.4
9.8
38
946
E03.0
ICD-10 Finland
Congenital hypothyroidism with diffuse goitre
12.1
9.8
17
14
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
6.3
9.8
25
40
RJ425
NOMESCO Finland
NA
25.9
9.8
13
5
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
10.6
9.7
18
17
S05.0
ICD-10 Finland
Injury of conjunctiva and corneal abrasion without mention of foreign body
2.6
9.7
69
268
K29.4
ICD-10 Finland
Chronic atrophic gastritis
6.5
9.7
24
37
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
9.6
774
6184
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
9.6
75
306
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
0.5
9.5
80
1521
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.5
9.5
315
2140
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.4
9.5
433
3146
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.7
9.5
460
5964
A10BH01
ATC
sitagliptin; oral
0.0
9.5
*
268
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
5.2
9.5
28
54
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.1
9.4
22
31
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
9.4
155
871
RJ212
NOMESCO Finland
NA
29.9
9.4
12
*
3643
FHL
Vitrectomy through pars Plana
29.9
9.4
12
*
SPAT1310
SPAT
Counselling related to known health issue
1.3
9.4
770
6165
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
9.4
325
2230
R2110
NOMESCO Finland
Giving the first information
1.8
9.3
170
983
N02CC07
ATC
frovatriptan; oral
0.3
9.3
25
725
RS120
NOMESCO Finland
NA
5.3
9.3
27
51
J35.0
ICD-10 Finland
Chronic tonsillitis
0.5
9.3
79
1496
W78
ICPC
Pregnancy
0.7
9.3
362
4864
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
2.3
9.3
85
378
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
9.2
208
1283
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.8
9.0
36
94
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
8.3
9.0
19
23
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.4
9.0
44
997
RJ123
NOMESCO Finland
NA
36.6
9.0
11
*
A08.0
ICD-10 Finland
Rotaviral enteritis
3.7
8.9
37
100
MA3AE
NOMESCO Finland
Combined first trimester screening
0.5
8.9
63
1260
TK820
NOMESCO Finland
Peritoneal dialysis
6.1
8.9
23
38
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
8.8
47
154
H26.02
ICD-10 Finland
Presenil cataract
3.9
8.8
35
91
C08CA02
ATC
felodipine; oral
2.8
8.8
56
204
N05AX12
ATC
aripiprazole; systemic
0.4
8.8
48
1046
J45
ICD-10 Finland
Asthma
0.5
8.7
67
1308
N02CC05
ATC
almotriptan; oral
0.3
8.7
23
668
W90
ICPC
Uncompl labour/delivery livebirth
0.5
8.7
60
1212
O68.3
ICD-10 Finland
Labour and delivery complicated by biochemical evidence of fetal stress
4.4
8.7
30
69
R03DC03
ATC
montelukast; oral
0.6
8.7
186
2789
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.7
8.7
56
208
CD2S4
NOMESCO Finland
Photography of eye
6.6
8.6
21
32
QDH01
NOMESCO Finland
Excision of nail bed in toe
6.6
8.6
21
32
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.5
8.6
292
1995
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
0.3
8.6
23
665
E66.8
ICD-10 Finland
Other obesity
0.3
8.5
24
682
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
4.6
8.5
28
61
A10BK03
ATC
empagliflozin; oral
0.1
8.5
5
342
Z11
ICPC
Compliance/being ill problem
5.5
8.5
24
44
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
8.5
374
2694
FNC30
NOMESCO Finland
Aorto-coronary venous bypass with three distal anastomoses
16.2
8.5
13
8
S52.5
ICD-10 Finland
Fracture of lower end of radius
1.7
8.5
168
1000
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
0.5
8.5
72
1366
CKD20
NOMESCO Finland
Removal of vitreous body substitute
6.9
8.5
20
29
S10
ICPC
Boil/carbuncle
1.9
8.5
128
700
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
20.0
8.4
12
6
2448A
ICD-9 Finland
Acquired hypothyroidism, Other specified acquired hypothyroidism[HYPOTHYREOSIS POST THYREOIDITIDEM]
20.0
8.4
12
6
E16.9
ICD-10 Finland
Disorder of pancreatic internal secretion, unspecified
20.0
8.4
12
6
H18.8
ICD-10 Finland
Other specified disorders of cornea
5.1
8.4
25
49
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
8.4
561
4346
XF400
SPAT
NA
7.3
8.4
19
26
A10AC30
ATC
combinations; parenteral (insulins and analog. for injection, intermediate-acting)
89.8
8.4
9
*
H35.29
ICD-10 Finland
Other proliferative retinopathy
89.8
8.4
9
*
XCX10
NOMESCO Finland
Other photography of eye
89.8
8.4
9
*
G99.0*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy
89.8
8.4
9
*
G43
ICD-10 Finland
Migraine
0.5
8.4
47
1015
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
0.7
8.4
343
4578
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
4.3
8.4
29
67
E109, E103
ICD-10 Finland
NA
+∞
8.3
8
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.8
8.3
26
54
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
6.2
8.3
21
34
RS224
NOMESCO Finland
NA
3.7
8.3
34
92
RK412
NOMESCO Finland
NA
14.4
8.2
13
9
SPAT1375
SPAT
Structural ultrasound screening, weeks 18+0-21+6
0.1
8.1
*
261
I79.2*E10.5
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
33.2
8.1
10
*
L04AA06
ATC
mycophenolic acid; systemic
2.6
8.0
55
210
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
0.4
8.0
36
845
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
8.0
151
886
RD240
NOMESCO Finland
NA
10.0
8.0
15
15
H03BB01
ATC
carbimazole; oral
2.2
8.0
74
333
RJ514
NOMESCO Finland
NA
21.9
8.0
11
5
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
5.0
8.0
24
48
V03AE02
ATC
sevelamer; oral
6.2
8.0
20
32
EMB10
NOMESCO Finland
Tonsillectomy
0.6
8.0
110
1824
C09CA03
ATC
valsartan; oral
2.3
7.9
73
325
N05AX08
ATC
risperidone; systemic
0.5
7.9
62
1201
P72
ICPC
Schizophrenia
0.1
7.9
*
304
A10BJ06
ATC
semaglutide; parenteral
0.0
7.9
*
196
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
4.7
7.9
25
53
I25.2
ICD-10 Finland
Old myocardial infarction
3.8
7.9
31
81
SPAT1336
SPAT
Request for examination
2.2
7.9
78
361
J01DB01
ATC
cefalexin; oral
1.3
7.9
2188
20247
R96
ICPC
Asthma
0.4
7.8
42
920
C07AG02
ATC
carvedilol; oral
3.2
7.8
38
118
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
7.8
7
361
H02AB07
ATC
prednisone; oral
0.5
7.8
73
1341
78410
ICD-8 Finland
Symptoms referable to upper gastro-intestinal tract, Emesis
9.4
7.7
15
16
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.7
7.7
359
4702
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
0.2
7.7
11
435
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
2.3
7.7
66
284
6481B
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Thyroid dysfunction[HYPOTHYREOSIS IN GRAVIDITATE]
44.8
7.7
9
*
E16.10
ICD-10 Finland
Hyperinsulinism
15.0
7.7
12
8
N08.30
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
15.0
7.7
12
8
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
2.2
7.6
71
318
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
4.2
7.6
27
64
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
5.9
7.6
20
34
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
7.6
797
6572
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.7
7.6
24
51
24409
ICD-8 Finland
Myxoedema, (hypothyreosis) NUD
18.3
7.6
11
6
M03BC01
ATC
orphenadrine (citrate); systemic
0.7
7.6
308
4119
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
2.2
7.6
69
310
382
Kela drug reimbursment
Insulin glargine 300 U / ml
24.9
7.5
10
*
H3601, E109
ICD-10 Finland
NA
24.9
7.5
10
*
JL9AE
NOMESCO Finland
Ultrasound examination of pancreas transplant
24.9
7.5
10
*
RK230
NOMESCO Finland
NA
6.7
7.5
18
27
N05AH02
ATC
clozapine; systemic
0.3
7.5
12
448
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
10.0
7.5
14
14
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.9
7.5
29
75
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.5
7.5
281
1962
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
7.5
818
6780
NHQ40
NOMESCO Finland
Amputation of toe
7.1
7.4
17
24
WX404
NOMESCO Finland
Intravenous generell anesthesy
0.7
7.4
257
3530
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.8
7.4
23
48
25004
ICD-8 Finland
Diabetes mellitus, Nephropathia diabetica. Polyneuritis diabetica
79.8
7.4
8
*
A02BC02
ATC
pantoprazole; systemic
0.8
7.4
851
9921
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
0.5
7.3
76
1354
D01AC02
ATC
miconazole; topical
1.8
7.3
116
647
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
2.5
7.3
54
216
A10AA04
ATC
NA
+∞
7.3
7
*
2550B
ICD-9 Finland
Disorders of adrenal glands, Cushing's syndrome[SYNDROMA CUSHING E HYPERFUNCTIO GLAN SUPRARENALI]
+∞
7.3
7
*
R03BA01
ATC
beclometasone; inhalant
0.6
7.3
99
1646
196
Kela drug reimbursment
Paricalcitol and cinacalcet
6.8
7.2
17
25
RJ412
NOMESCO Finland
NA
9.3
7.2
14
15
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
7.2
203
1330
L86
ICPC
Back syndrome with radiating pain
0.3
7.2
18
535
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
5.4
7.2
20
37
K50.8
ICD-10 Finland
Other Crohn disease
0.1
7.2
*
260
Z51.88
ICD-10 Finland
Other specified medical care
3.3
7.2
33
99
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
3.0
7.2
39
132
N18.8
ICD-10 Finland
Other chronic renal failure
2.9
7.1
41
141
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.2
7.1
70
323
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
7.1
396
2972
4019X
ICD-9 Finland
Essential hypertension, Unspecified
19.9
7.1
10
5
O12.1
ICD-10 Finland
Gestational proteinuria
3.7
7.1
29
79
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
1.5
7.1
231
1565
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
7.9
7.1
15
19
C03AA03
ATC
hydrochlorothiazide; oral
2.7
7.1
46
173
L05.0
ICD-10 Finland
Pilonidal cyst with abscess
2.4
7.1
54
223
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
7.0
444
3401
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
5.6
7.0
19
34
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
0.4
6.9
38
827
S91.3
ICD-10 Finland
Open wound of other parts of foot
2.2
6.9
64
289
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
4.9
6.9
21
43
C09DA06
ATC
candesartan and diuretics; oral
2.4
6.9
56
239
I25
ICD-10 Finland
Chronic ischaemic heart disease
5.8
6.9
18
31
N89
ICPC
Migraine
0.4
6.9
35
778
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.9
6.8
87
451
NB1AE
SPAT
NA
2.5
6.8
49
196
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.8
242
1671
H02AB02
ATC
dexamethasone; systemic
0.4
6.8
24
614
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.3
6.8
32
98
C02CA01
ATC
prazosin; oral
8.2
6.8
14
17
Z36.2
ICD-10 Finland
Other antenatal screening based on amniocentesis
9.3
6.8
13
14
WZC30
SPAT
NA
3.2
6.7
33
104
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.5
6.7
205
1369
H36
ICD-10 Finland
Retinal disorders in diseases classified elsewhere
39.8
6.7
8
*
RJ516
NOMESCO Finland
NA
39.8
6.7
8
*
G59.0*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic mononeuropathy
39.8
6.7
8
*
BEF00
SPAT
NA
39.8
6.7
8
*
O66.0
ICD-10 Finland
Obstructed labour due to shoulder dystocia
5.3
6.7
19
36
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
16.6
6.7
10
6
WW200
SPAT
NA
1.5
6.7
238
1643
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
5.6
6.7
18
32
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
3.7
6.7
27
73
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
6.7
246
1713
114
Kela drug reimbursment
Glaucoma
3.1
6.7
33
105
J01MA06
ATC
norfloxacin; oral
1.6
6.7
171
1098
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
0.7
6.6
212
2952
S92.3
ICD-10 Finland
Fracture of metatarsal bone
1.9
6.6
95
513
N05CF02
ATC
zolpidem; oral
0.7
6.6
161
2355
CHC05
NOMESCO Finland
Iridotomy
5.9
6.6
17
29
S01EC54
ATC
brinzolamide, combinations; ophthalmic
12.2
6.6
11
9
QBA10
NOMESCO Finland
Incision of skin of trunk
3.2
6.6
32
101
E14.1
ICD-10 Finland
Unspecified diabetes mellitus, with ketoacidosis
10.0
6.5
12
12
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
3.0
6.5
34
113
V03AE03
ATC
lanthanum carbonate; oral
6.8
6.5
15
22
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
6.8
6.5
15
22
N06AX11
ATC
mirtazapine; oral
0.8
6.5
395
4987
L12
ICPC
Hand/finger symptom/complaint
1.4
6.5
348
2600
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.5
6.4
239
1667
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.6
6.4
156
988
O70.1
ICD-10 Finland
Second degree perineal laceration during delivery
0.3
6.4
17
494
RJ127
NOMESCO Finland
NA
69.6
6.4
7
*
RJ310
NOMESCO Finland
NA
69.6
6.4
7
*
C05AA08
ATC
fluocortolone; rectal, topical
0.6
6.4
78
1333
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.2
6.4
8
337
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
2.6
6.3
42
161
N18.0
ICD-10 Finland
End-stage renal disease
3.9
6.3
24
62
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
1.6
6.3
153
967
R76.0
ICD-10 Finland
Raised antibody titre
4.9
6.3
19
39
RD213
NOMESCO Finland
NA
8.1
6.3
13
16
RS211
NOMESCO Finland
NA
3.0
6.3
33
110
SPAT1153
SPAT
Removal of sutures
1.3
6.3
459
3595
2512B
ICD-9 Finland
Other disorders of pancreatic internal secretion, Hypoglycaemia, unspecified[HYPOGLYCAEMIA ALIA (SINE HYPERINSULINISMO)]
+∞
6.2
6
*
H3609, E109
ICD-10 Finland
NA
+∞
6.2
6
*
2506B
ICD-9 Finland
Diabetes mellitus, Diabetes with neurological manifestations[MICROANGIOPATHIA DIABETICA,TYYPPI I]
+∞
6.2
6
*
N08.31
ICD-10 Finland
Glomerular disorders in diabetes mellitus macroalbuminuria
+∞
6.2
6
*
S18
ICPC
Laceration/cut
1.3
6.2
733
6108
64090
ICD-8 Finland
Artificial termination of pregnancy performed for medical reasons, Woman's illness or physical defect (medicines. Cause)
26.6
6.2
8
*
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
4.7
6.2
19
40
M79.1
ICD-10 Finland
Myalgia
0.7
6.2
138
2051
S01EA03
ATC
apraclonidine; ophthalmic
6.2
6.1
15
24
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.2
6.1
1494
13436
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
2.1
6.1
63
298
L11
ICPC
Wrist symptom/complaint
1.5
6.1
199
1353
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
0.5
6.1
55
1017
SPAT1197
SPAT
Extensive health check-up of expecting family
0.8
6.1
348
4430
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.0
1565
14152
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.8
6.0
23
60
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
0.1
6.0
*
183
SPAT1189
SPAT
Other ultrasound examination during pregnancy
0.5
6.0
40
815
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.1
6.0
65
316
T29
ICPC
Endocr/metab/nutr sympt/compl other
3.3
6.0
28
86
F51.0
ICD-10 Finland
Nonorganic insomnia
0.7
6.0
178
2512
RJ511
NOMESCO Finland
NA
10.0
6.0
11
11

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
481
224
25.10
307.65
3.0
2.7
ug/min
97.1
167.5
0.77
332
156
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2974
18314
13.94
307.65
13.6
3.4
mmol/mol
61.0
36.3
307.65
2867
17501
(3009508) Creatinine [Moles/volume] in Urine
2751
5150
37.27
307.65
5.6
3.7
mmol/l
13.9
9.0
0.49
2535
4570
(3020682) Albumin/Creatinine [Ratio] in Urine
2814
3077
82.96
307.65
7.1
4.1
mg/mmol
9.2
18.7
1.11
2176
2130
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1644
4608
6.39
307.65
2.1
1.6
mmol/l
1.0
1.5
46.42
1421
4134
(3012516) Albumin [Mass/volume] in Urine
2732
2968
66.24
307.65
5.7
3.4
mg/l
107.1
416.3
3.11
2089
2025
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
2005
7402
5.74
307.65
2.4
1.4
u/ml
2.6
1.9
0.85
574
1921
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
134
34
40.97
220.38
1.6
2.0
ug/min
74.7
148.4
—
37
5
(4146454)
148
67
23.05
202.06
4.4
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2000
11408
3.08
195.05
7.6
4.7
mmol/l
10.6
6.1
239.13
1812
10310
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
285
401
7.69
193.42
8.3
3.0
nmol/l
0.3
0.9
28.17
224
356
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2967
22084
7.77
182.34
7.2
3.1
mmol/l
2.5
2.9
215.22
2837
21036
(3007164) IgA [Mass/volume] in Serum or Plasma
1368
6635
2.87
175.04
1.6
1.5
g/l
2.2
2.1
2.09
641
4168
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2924
21754
6.32
173.28
7.3
4.1
mu/l
1.9
2.0
0.37
2775
20725
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2910
22056
5.61
156.20
6.5
3.0
mmol/l
4.3
4.7
140.68
2779
21172
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2895
21931
5.31
153.68
6.5
3.0
mmol/l
1.5
1.4
85.54
2758
21009
(3023103) Potassium [Moles/volume] in Serum or Plasma
2958
22803
6.53
153.01
14.5
9.4
mmol/l
4.0
3.9
17.80
2871
22032
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2820
21047
4.45
150.90
5.4
2.8
mmol/l
1.0
1.3
126.13
2658
20165
(3019550) Sodium [Moles/volume] in Serum or Plasma
2945
22725
6.10
149.61
14.2
9.4
mmol/l
138.5
139.6
128.11
2859
22037
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
124
76
16.88
147.43
2.2
2.1
mmol/l
2.1
1.6
0.44
109
47
(3000034) Microalbumin [Mass/volume] in Urine
126
97
13.44
132.20
3.8
2.8
mg/l
80.2
78.7
0.01
95
69
(36660697) Celiac disease serology panel - Serum
725
2842
3.01
132.02
1.4
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1483
8863
2.27
106.68
2.8
2.5
nmol/l
70.0
69.9
0.05
1322
8416
(3021447) Carbon dioxide [Partial pressure] in Venous blood
549
2112
2.93
101.18
5.4
7.0
kpa
5.7
5.9
3.98
526
2055
(3002032) Base excess in Venous blood by calculation
541
2101
2.89
97.75
5.5
7.0
mmol/l
1.1
1.6
2.25
422
1728
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
209
443
4.96
92.34
1.1
1.2
iu/ml
28541.7
3184.7
0.43
78
125
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2629
20607
2.71
92.17
11.3
7.5
ml/min/173m2
101.7
100.1
2.63
2085
16269
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2462
18741
2.46
91.56
5.7
3.7
pmol/l
14.6
14.4
5.75
2308
17525
(3004775) Volume in Urine collected for unspecified duration
94
85
11.33
88.99
2.6
2.5
ml
615.6
668.6
0.37
61
63
(3022689) Creatine [Moles/volume] in Urine
63
32
19.99
81.50
1.3
1.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
470
1874
2.76
79.77
4.2
6.9
kpa
5.1
5.0
0.35
448
1824
(3020564) Creatinine [Moles/volume] in Serum or Plasma
2955
25638
3.75
67.85
14.0
9.3
umol/l
72.8
70.6
2.78
2955
25625
(3008295) Osmolality of Serum or Plasma
116
197
6.05
65.17
2.6
1.7
mosm/kgh2o
300.7
286.4
8.34
85
157
(3016750) Collection duration of Urine
75
77
9.92
64.96
2.5
2.5
min
490.6
510.4
0.85
52
61
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
25
3101
0.07
63.51
1.8
2.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
822
4585
2.07
63.28
1.9
2.2
u/l
174.4
279.9
2.51
769
4383
(3000991) Gas panel - Venous blood
447
1955
2.49
61.93
9.9
9.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
479
2263
2.31
55.43
1.3
1.2
iu/ml
205.3
142.6
1.36
204
812
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
1579
0.05
52.86
2.2
1.8
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
373
1619
2.47
52.08
5.5
7.3
mmol/l
22.6
24.2
12.09
351
1545
(3003458) Phosphate [Moles/volume] in Serum or Plasma
512
2593
2.16
49.59
10.9
8.4
mmol/l
1.1
1.1
0.01
488
2473
(3027273) Bicarbonate [Moles/volume] in Venous blood
190
597
3.31
48.45
5.0
4.6
mmol/l
24.8
24.9
0.13
183
575
(3004119) Hemoglobin [Mass/volume] in Venous blood
231
858
2.82
43.97
5.1
5.9
g/l
131.3
135.6
2.11
225
839
(3008116) Ketones [Moles/volume] in Urine by Test strip
48
46
10.54
43.57
1.6
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
477
2488
2.07
42.27
1.9
2.2
nmol/l
438.0
361.3
12.49
446
2311
(3016273) Islet cell 512 Ab [Units/volume] in Serum
49
51
9.71
41.96
1.1
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1445
18324
0.60
41.46
3.2
3.1
u/l
33.7
36.6
1.13
1371
17682
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
169
561
3.12
39.29
4.8
4.6
%
49.7
54.5
1.42
169
554
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
124
3605
0.32
37.89
1.3
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
361
1770
2.17
37.36
10.1
8.2
mmol/l
103.0
104.9
11.54
346
1738
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1703
20539
0.62
36.89
3.6
2.9
mmol/l
9.3
5.5
215.32
1504
19342
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1186
8615
1.60
32.96
10.5
7.2
mmol/l
1.2
1.2
2.63
1008
7401
(3014111) Lactate [Moles/volume] in Serum or Plasma
306
1499
2.15
31.55
10.5
9.0
mmol/l
1.3
1.4
1.25
289
1424
(3002385) Erythrocyte distribution width [Ratio]
2573
22623
1.75
30.68
15.4
12.1
%
12.8
13.2
58.93
2501
22193
(3028626) Oxygen [Partial pressure] in Capillary blood
249
1135
2.29
30.63
3.6
6.7
kpa
9.8
9.7
0.32
239
1082
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
327
1679
2.05
29.71
3.6
6.0
kpa
4.9
5.1
4.17
311
1597
(3021901) Oxygen saturation in Capillary blood
100
285
3.58
29.67
2.4
4.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1072
7804
1.56
28.43
10.1
7.1
mmol/l
1.2
1.2
0.57
973
7242
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
78
2510
0.29
28.35
1.2
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
322
1674
2.02
28.22
3.7
6.0
ph
7.4
7.4
0.84
45
133
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
317
1643
2.03
28.01
3.6
6.0
mmol/l
1.0
1.1
0.15
200
1178
(3015235) Bicarbonate [Moles/volume] in Capillary blood
125
433
2.95
26.98
2.9
5.9
mmol/l
22.8
23.7
1.60
111
393
(3016502) Oxygen saturation in Arterial blood
247
1184
2.17
26.81
11.2
10.1
%
96.3
96.4
0.07
236
1144
(3003396) Base excess in Arterial blood by calculation
272
1371
2.07
25.89
10.6
9.2
mmol/l
-0.5
0.7
3.01
204
1050
(40761511) CBC panel - Blood by Automated count
2877
26481
2.04
25.70
11.8
8.4
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
270
1370
2.05
25.23
10.9
9.2
kpa
13.3
14.3
2.67
254
1310
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
270
1371
2.05
25.18
10.9
9.2
kpa
4.8
5.1
5.87
254
1308
(3002173) Hemoglobin [Mass/volume] in Arterial blood
230
1100
2.17
25.09
11.8
10.0
g/l
121.7
126.7
2.45
216
1059
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
310
1665
1.95
24.65
3.3
3.5
pmol/l
4.6
4.8
1.17
282
1499
(3008037) Lactate [Moles/volume] in Venous blood
76
210
3.67
23.65
2.5
3.0
mmol/l
1.5
1.5
0.21
76
203
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
139
559
2.55
22.54
2.4
2.0
g/l
1.2
1.3
0.53
125
494
(3045683) HLA typing for celiac disease panel - Blood or Tissue
82
247
3.37
22.40
1.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
49
104
4.75
21.60
7.3
8.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2818
25993
1.82
21.58
10.1
7.9
u/l
24.1
29.0
37.96
2705
25301
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
242
1248
2.01
21.57
8.2
5.7
ng/l
113.8
70.3
5.26
222
1172
(3026250) Tacrolimus [Mass/volume] in Blood
68
190
3.62
20.85
50.3
41.7
ug/l
8.5
7.3
5.99
68
176
(40768446) Kidney Pathology biopsy report
61
158
3.90
20.84
2.0
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
421
2663
1.66
19.13
4.0
2.5
g/l
2.2
2.5
15.34
396
2485
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
391
2432
1.69
18.93
4.2
2.6
%
24.8
24.4
0.26
346
2147
(3022948) Iron [Moles/volume] in Serum or Plasma
454
2940
1.63
18.78
3.9
2.5
umol/l
13.7
14.9
3.63
428
2767
(3008152) Bicarbonate [Moles/volume] in Arterial blood
147
659
2.28
18.78
7.5
7.8
mmol/l
22.9
24.2
2.36
131
611
(3020961) Endomysium IgA Ab [Titer] in Serum
322
1909
1.76
18.53
1.5
1.2
titre
105.4
222.6
0.56
26
51
(21494755) Public health laboratory ask at order entry panel
281
4639
0.56
18.47
1.1
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1369
11115
1.40
18.45
8.0
8.7
e9/l
0.0
0.0
4.09
1108
8990
(3042733) HLA Ab [Presence] in Serum
51
127
4.05
18.42
4.8
4.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
21
21
10.02
18.40
6.1
5.5
mmol/l
5.7
7.4
0.51
21
21
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
40
82
4.91
18.39
2.7
7.5
mg/l
2.5
2.3
0.24
40
66
(3044889) 12 lead EKG panel
1541
12795
1.39
18.05
2.8
2.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
108
433
2.54
17.67
3.4
3.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
105
421
2.54
17.19
4.7
6.7
%
1.1
0.9
0.28
97
390
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
106
428
2.52
17.10
4.8
6.6
%
1.6
1.8
0.99
100
393
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
813
6083
1.45
17.02
1.7
1.6
pmol/l
100.9
99.0
0.46
329
3417
(3038515) Glucose [Moles/volume] in Venous blood
61
187
3.29
16.29
2.6
2.8
mmol/l
12.2
6.6
6.63
61
182
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
145
692
2.14
15.91
13.8
12.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
97
393
2.51
15.56
5.6
7.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
115
505
2.32
15.46
1.7
1.4
ug/g
258.3
331.3
3.84
81
253
(3001019) Free T4 and TSH panel - Serum or Plasma
93
2064
0.43
14.83
1.5
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
597
7927
0.69
14.28
1.8
1.8
—
—
—
0
0
(3020891) Body temperature
111
499
2.26
14.15
6.5
5.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
62
210
2.98
14.06
1.5
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
313
4722
0.62
13.97
1.8
1.8
%
1.6
1.4
5.19
274
4311
(3024932) HLA-DR beta [Type]
44
122
3.63
13.74
1.0
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
49
147
3.36
13.59
1.3
1.2
u/l
68.0
123.7
0.92
40
100
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
180
982
1.88
13.59
1.1
1.1
u/ml
19.4
4.1
0.77
20
163
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
135
669
2.06
13.46
2.0
2.1
iu/l
3.6
4.6
0.85
54
267
(3024471) HLA-A [Type]
44
124
3.57
13.42
1.0
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
575
7609
0.70
13.31
2.1
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
226
1338
1.74
13.01
3.9
6.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
275
1722
1.65
12.84
16.2
10.6
mmol/l
9.7
6.2
16.32
264
1673
(3043409) Potassium [Moles/volume] in Arterial blood
77
307
2.54
12.83
4.8
4.4
mmol/l
3.9
3.8
0.67
69
285
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
224
1328
1.73
12.83
2.9
2.2
ml/min/173m2
73.0
84.4
2.23
88
478
(1761482) Bacteria [#/volume] in Urine by Culture
71
272
2.64
12.83
2.6
2.4
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
72
280
2.60
12.63
3.1
1.8
mu/l
61.2
76.3
0.44
67
251
(3018418) pH of Serum or Plasma
635
4771
1.41
12.45
7.6
3.9
ph
7.4
7.4
2.64
131
931
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
649
8326
0.72
12.31
2.1
2.3
—
—
—
0
0
(3010421) pH of Blood
106
501
2.15
11.99
4.7
3.8
ph
7.4
7.4
1.76
83
428
(3026008) Bacteria identified in Urine by Culture
627
4738
1.40
11.82
2.7
2.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
129
660
1.99
11.81
5.1
5.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
153
836
1.87
11.52
2.0
2.4
g/l
64.1
67.8
8.67
145
800
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
136
723
1.91
11.15
15.5
11.6
mmol/l
22.9
24.1
2.58
130
694
(3033705) Calcium.ionized [Moles/volume] in Venous blood
37
108
3.44
10.76
2.0
2.0
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
260
1694
1.58
10.30
4.1
4.6
u/l
231.1
232.7
0.11
255
1616
(3013512) EKG study
504
3749
1.40
10.30
3.2
2.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
79
354
2.25
10.24
2.7
2.3
%
16.9
18.0
1.97
55
174
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
22
45
4.90
10.20
1.2
1.8
ng/l
5.3
16.9
1.51
12
25
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
212
1321
1.64
10.10
4.1
6.0
mmol/l
23.6
24.3
2.55
205
1289
(3022145) Colonoscopy Study observation
121
2134
0.55
9.74
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3017
29172
1.89
9.58
18.8
14.0
e9/l
274.7
260.2
31.79
2947
28449
(3040151) Glucose [Moles/volume] in Capillary blood
55
219
2.53
9.29
19.7
3.5
mmol/l
12.3
6.6
8.02
50
185
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
419
3074
1.41
9.22
1.5
1.5
pmol/l
475.4
41855791.5
2.97
342
2738
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
194
1212
1.63
9.16
4.2
3.4
mmol/l
1.2
1.2
0.47
157
1051
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2338
24749
0.77
9.07
3.5
3.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
105
551
1.93
9.01
1.4
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
637
5023
1.33
8.89
2.3
2.4
mg/l
2.6
2.6
0.17
554
4393
(3045716) Anion gap in Serum or Plasma
23
55
4.19
8.86
6.6
2.6
mmol/l
12.2
9.4
0.93
16
42
(3024731) MCV [Entitic volume]
3017
29220
1.84
8.81
18.7
13.9
fl
88.4
88.8
5.59
2975
28919
(3035941) MCH [Entitic mass]
3017
29223
1.83
8.76
18.7
13.9
pg
29.8
29.8
0.58
2975
28919
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
179
2.64
8.70
1.6
2.3
mg/l
34.9
28.0
0.49
38
141
(3034860) Kappa light chains.free [Mass/volume] in Serum
47
179
2.64
8.70
1.7
2.3
mg/l
43.8
34.9
0.68
38
143
(3006184) Hemoglobin [Mass/volume] in Capillary blood
78
373
2.11
8.66
2.4
2.4
g/l
132.0
137.3
1.18
68
291
(3026361) Erythrocytes [#/volume] in Blood
3017
29230
1.83
8.65
18.8
14.0
e12/l
4.6
4.7
4.19
2939
28474
(3048689) Calprotectin [Mass/mass] in Stool
319
4369
0.70
8.46
2.0
3.0
ug/g
109.1
111.9
0.06
238
3546
(3010813) Leukocytes [#/volume] in Blood
3017
29247
1.81
8.38
18.8
14.0
e9/l
6.5
6.7
5.54
2941
28474
(3000963) Hemoglobin [Mass/volume] in Blood
3017
29248
1.81
8.37
19.0
14.1
g/l
137.7
139.1
6.75
2976
28937
(3023520) Reticulocytes [#/volume] in Blood
185
1172
1.61
8.28
3.2
3.6
e9/l
70.3
68.8
0.18
127
804
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
168
1047
1.63
8.04
6.3
11.7
mg/l
1.6
1.1
14.88
158
1015
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
24
64
3.76
8.01
3.3
3.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
368
2705
1.40
7.98
1.9
1.6
—
—
—
0
0
(3025315) Body weight
11
14
7.85
7.95
4.9
2.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
85
434
1.98
7.94
3.9
3.9
mmol/l
2.4
1.9
0.88
51
266
(3003181) Sodium [Moles/volume] in Urine
52
218
2.40
7.92
3.3
2.0
mmol/l
65.8
84.4
2.23
45
186
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
30
96
3.13
7.62
1.8
1.5
u/l
17.5
4.2
1.37
15
48
(3000330) Specific gravity of Urine by Test strip
121
701
1.75
7.62
2.9
2.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
40
151
2.66
7.58
1.1
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
339
2.08
7.57
3.4
8.0
u/ml
0.3
0.3
0.82
27
175
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
8
365
0.22
7.23
12.3
21.9
nmol/l
1608.5
1364.5
—
8
353
(3027945) Reticulocytes/100 erythrocytes in Blood
253
1770
1.46
7.19
3.3
4.6
%
1.7
1.5
1.51
233
1630
(46235355) HIV 1 and 2 tests - Meaningful Use set
892
10374
0.80
7.19
2.2
2.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
40
156
2.57
7.12
1.1
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
278
3788
0.70
7.09
1.9
2.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
516
4070
1.31
7.06
4.3
4.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
246
1720
1.46
7.02
5.1
4.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
11
17
6.46
6.74
1.7
3.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
547
6694
0.77
6.70
1.8
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
519
4130
1.30
6.63
3.4
2.6
e6/l
5.8
7.1
0.96
469
3629
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
253
1799
1.44
6.61
6.0
2.7
%
37.6
30.2
17.82
172
1397
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
365
4709
0.74
6.58
2.1
2.1
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
22
64
3.44
6.51
1.2
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
680
8067
0.79
6.37
1.9
1.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
77
412
1.88
6.34
2.7
2.6
mg/l
19.2
25.6
1.25
46
265
(3042936) Bacteria identified in Isolate by Culture
348
2636
1.35
6.26
2.8
2.0
—
—
—
0
0
(3026782) Osmolality of Urine
493
3926
1.30
6.24
3.3
2.6
mosm/kgh2o
417.4
578.0
1.20
439
3375
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
265
3562
0.72
6.20
1.5
1.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
312
2.00
6.12
1.4
1.5
g/l
3.1
3.8
6.14
39
236
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
312
2.00
6.12
1.4
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
62
312
2.00
6.12
1.4
1.5
g/l
7.4
7.1
0.56
40
252
(3035637) Corticotropin [Mass/volume] in Plasma
79
433
1.84
6.05
1.7
1.7
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
87
492
1.78
6.02
5.2
6.1
—
1065.2
—
0
32
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
108
1712
0.62
5.83
1.4
1.6
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
63
325
1.95
5.81
5.8
4.0
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
288
2152
1.37
5.66
1.6
1.6
nmol/l
1355.3
1150.3
2.77
219
1691
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
55
274
2.02
5.61
1.5
1.5
pmol/l
316.4
372.1
0.33
38
209
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
153
2227
0.67
5.58
1.0
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
89
525
1.71
5.36
3.3
2.8
ug/l
241.6
307.1
0.50
82
479
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
36
154
2.34
5.35
1.2
1.4
nmol/l
0.7
1.4
4.01
23
139
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
108
1667
0.63
5.22
1.7
1.8
ug/l
0.5
0.5
0.09
52
653
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
813
9306
0.82
5.19
1.6
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
745
8592
0.82
5.13
1.7
1.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
55
285
1.94
5.05
1.4
1.5
g/l
9.3
10.7
2.15
45
258
(40760888) Immunoglobulin light chains.free panel - Serum
34
146
2.33
5.03
1.7
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
57
301
1.90
4.96
1.4
1.5
g/l
2.9
3.1
0.39
40
247
(3003338) MCHC [Mass/volume]
2545
24293
1.24
4.92
16.2
11.9
g/l
336.1
334.9
9.05
2540
24077
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
124
816
1.53
4.84
2.2
1.9
ug/l
6.8
7.8
0.27
104
724
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
58
311
1.87
4.83
1.4
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
86
1368
0.62
4.76
1.5
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
18
57
3.16
4.73
1.7
3.1
ph
7.4
7.4
—
5
11
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
52
271
1.93
4.72
1.4
1.5
g/l
0.2
0.5
0.60
45
256
(3012095) Magnesium [Moles/volume] in Serum or Plasma
348
2764
1.29
4.48
5.0
5.8
mmol/l
0.8
0.8
2.48
322
2614
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
76
456
1.68
4.37
1.2
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
513
6048
0.81
4.31
4.4
4.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
97
623
1.57
4.25
12.1
7.6
iu/ml
845.5
705.9
0.12
24
82
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
72
430
1.68
4.22
1.3
1.4
—
—
—
0
0
(4034850)
92
585
1.58
4.21
5.7
7.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
81
500
1.63
4.19
2.4
2.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
119
803
1.49
4.17
2.2
1.7
u/ml
106.2
97.7
0.49
23
130
(3021387) Prolactin [Units/volume] in Serum or Plasma
152
2078
0.71
3.97
1.6
1.6
mu/l
295.0
298.9
0.08
134
1873
(3002582) Erythrocytes [#/volume] in Urine
700
6080
1.19
3.86
4.0
3.1
e6/l
27.5
87.0
1.41
579
4568
(3011648) Oxygen content in Venous blood
37
185
2.00
3.84
4.4
12.5
%
11.3
12.1
0.88
37
185
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
33
641
0.51
3.81
1.4
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1186
12905
0.86
3.80
6.0
7.0
e9/l
1.9
2.0
11.83
1032
11584
(3021960) Folate [Moles/volume] in Serum or Plasma
396
3263
1.24
3.75
1.5
1.4
nmol/l
20.1
19.6
0.41
360
2966
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
45
245
1.84
3.66
1.5
1.4
g/l
36.8
39.8
2.21
39
226
(3000492) Spirometry study
217
2773
0.76
3.63
1.4
1.4
—
—
—
0
0
(1002224) Polysomnography panel
92
1351
0.67
3.59
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
177
2315
0.75
3.50
1.1
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
120
843
1.43
3.48
2.2
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
170
2232
0.74
3.46
1.8
2.2
%
24.8
21.2
0.69
31
446
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
405
4783
0.82
3.42
1.5
1.5
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
13
344
0.37
3.37
2.1
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
171
2233
0.75
3.35
1.7
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
42
3.09
3.34
1.8
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
42
3.09
3.34
1.8
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
354
0.39
3.29
1.2
1.4
—
—
—
0
0
(4010399)
85
1237
0.68
3.20
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
103
1439
0.70
3.12
1.1
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
54
860
0.62
3.11
2.0
2.9
umol/l
8.6
6.9
0.38
42
665
(3019420) Tryptase [Mass/volume] in Serum or Plasma
5
184
0.27
3.08
1.2
1.4
ug/l
48.1
6.5
—
5
161
(3018095) Leukocytes [#/volume] in Urine
837
7498
1.15
3.06
4.7
3.6
e6/l
133.6
55.0
1.35
617
4940
(3037756) Immunofixation for Serum or Plasma
26
125
2.08
3.05
1.3
1.5
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
1151
12417
0.88
3.04
5.9
6.9
%
28.8
31.2
11.50
1084
11821
(3013115) Eosinophils [#/volume] in Blood
1189
12799
0.88
3.03
6.2
7.5
e9/l
0.2
0.2
2.89
1025
11441
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
7
12
5.82
3.01
5.0
2.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1290
13809
0.88
3.00
7.4
9.7
e9/l
4.2
3.9
4.80
1115
12061
(3011412) CD3 cells [#/volume] in Blood
16
365
0.43
2.96
2.8
3.1
e9/l
0.9
1.3
—
9
226
(3030467) Casts [#/volume] in Urine by Automated count
634
5577
1.17
2.95
4.0
3.0
e6/l
0.4
0.2
0.36
515
4122
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
130
957
1.37
2.93
3.1
4.4
g/l
3.7
3.3
2.78
124
923
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
277
0.36
2.91
1.5
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2592
25072
1.17
2.89
11.6
9.6
mg/l
19.3
20.6
1.32
1941
18489
(3001604) Monocytes [#/volume] in Blood
1148
12355
0.88
2.87
6.0
7.1
e9/l
0.5
0.5
0.67
981
10844
(3005322) IgE [Units/volume] in Serum or Plasma
168
2144
0.77
2.82
1.3
1.3
u/ml
482.0
290.5
0.40
158
2000
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
526
5969
0.85
2.81
1.5
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
88
610
1.45
2.81
1.1
1.1
u/ml
11.0
3.1
0.99
21
324
(3018010) Neutrophils/100 leukocytes in Blood
1137
12223
0.88
2.76
5.8
6.8
%
57.2
54.6
10.27
1072
11652
(3010726) Horse dander IgE Ab [Units/volume] in Serum
83
1171
0.70
2.70
1.1
1.1
u/ml
1.8
2.9
0.42
27
327
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
245
2970
0.81
2.68
2.1
2.2
ug/l
1.1
1.1
0.12
223
2747
(3006315) Basophils [#/volume] in Blood
1154
12377
0.89
2.67
6.0
7.1
e9/l
0.0
0.0
8.11
982
10854
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
157
2005
0.77
2.67
1.5
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
65
429
1.52
2.65
4.7
6.4
mmol/l
1.1
1.2
0.16
55
367
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
14
318
0.44
2.60
2.9
3.2
e6/l
331.8
521.1
—
9
252
(3039000) Anion gap in Blood
43
258
1.67
2.60
5.8
8.8
mmol/l
12.0
11.5
0.39
36
229
(40758292) HTLV I+II Ab panel - Serum
0
67
0.00
2.60
0.0
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
403
3452
1.19
2.59
1.3
1.2
u/ml
11.6
8.8
0.42
181
1421
(3022096) Basophils/100 leukocytes in Blood
1054
11350
0.89
2.59
6.0
7.2
%
0.7
0.7
4.11
997
10772
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
15
4.66
2.58
2.4
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
344
0.46
2.58
1.0
1.0
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
43
259
1.66
2.57
5.8
8.8
mmol/l
103.9
105.5
1.24
36
230
(3015183) Erythrocyte sedimentation rate
8
209
0.38
2.53
1.1
1.2
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
11
5.44
2.53
4.0
7.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
14
313
0.44
2.51
2.9
3.3
e9/l
0.2
0.2
—
9
251
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
936
10134
0.89
2.50
4.1
3.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
158
1233
1.29
2.44
4.1
3.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
145
1846
0.77
2.43
1.4
1.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
17
76
2.23
2.41
1.2
1.1
u/l
10.4
17.3
—
8
60
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
65
0.00
2.41
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
145
1844
0.77
2.41
1.4
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
110
2.00
2.38
1.3
2.5
u/field
2.5
2.0
—
8
67
(3003888) Timothy IgE Ab [Units/volume] in Serum
89
1210
0.72
2.36
1.1
1.1
u/ml
7.5
7.4
0.03
61
768
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
145
1838
0.78
2.35
1.4
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
31
175
1.77
2.35
2.5
1.6
mmol/l
12.3
5.5
5.09
23
146
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
145
1836
0.78
2.34
1.4
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
13
52
2.50
2.34
2.4
3.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
85
1162
0.72
2.34
1.1
1.1
u/ml
2.3
1.2
0.30
51
645
(3019069) Monocytes/100 leukocytes in Blood
1105
11807
0.90
2.30
6.1
7.2
%
8.0
8.2
1.27
1047
11242
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
17
78
2.18
2.28
1.2
1.1
u/l
68.2
79.3
—
9
65
(3025941) Bacteria identified in Stool by Culture
130
1663
0.77
2.27
1.3
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
45
284
1.59
2.27
3.1
4.2
u/ml
146.0
110.7
0.18
18
83
(3006504) Eosinophils/100 leukocytes in Blood
1097
11719
0.90
2.27
5.9
7.1
%
3.1
2.9
3.00
1033
11093
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
97
1292
0.74
2.27
1.1
1.2
u/ml
1.2
2.5
1.33
49
672
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
49
736
0.66
2.26
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
196
1587
1.25
2.26
2.5
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
283
2381
1.20
2.24
1.7
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
278
3265
0.83
2.23
1.5
2.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
278
3261
0.83
2.21
1.5
2.3
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
19
93
2.04
2.19
3.6
2.0
nmol/l
0.5
1.3
4.03
13
75
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
28
473
0.59
2.15
1.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
277
3241
0.84
2.14
1.5
2.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
18
345
0.52
2.13
1.3
1.1
%
93.3
94.2
0.03
18
324
(40761995) Spermatozoa Progressive [#/volume] in Semen
19
357
0.53
2.12
3.1
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
19
357
0.53
2.12
6.2
6.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
211
1736
1.23
2.11
1.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
129
1003
1.29
2.09
1.4
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
468
5243
0.87
2.09
1.9
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
31
505
0.61
2.07
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
275
3208
0.84
2.06
1.4
2.3
—
—
—
0
0
(3000012) Reticulocyte production index
14
62
2.25
2.05
1.4
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1621
15381
1.10
2.03
6.8
6.4
u/l
85.7
79.5
5.66
1536
14569
(3023323) Follitropin [Units/volume] in Serum or Plasma
169
2064
0.81
2.03
1.4
1.6
iu/l
13.1
15.2
0.54
138
1650
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
299
2555
1.18
2.02
1.8
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
216
2570
0.83
2.01
1.5
2.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
425
3735
1.15
2.01
1.3
1.3
iu/ml
21.2
20.5
0.06
125
1060
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
104
792
1.32
1.98
1.5
1.5
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
35
217
1.61
1.94
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
20
359
0.55
1.94
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
20
358
0.55
1.92
1.2
1.4
pmol/l
84.1
64.0
—
5
97
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
37
567
0.65
1.92
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
15
71
2.11
1.90
1.3
2.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
61
847
0.71
1.90
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
35
219
1.60
1.88
1.2
1.2
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
52
739
0.70
1.85
1.1
1.1
u/ml
2.7
0.5
0.37
17
213
(3009214) Lutropin [Units/volume] in Serum or Plasma
148
1813
0.80
1.85
1.5
1.7
u/l
7.1
7.1
0.03
115
1404
(3038177) Helicobacter pylori Ab [Presence] in Serum
34
526
0.64
1.85
1.2
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
262
3037
0.85
1.84
1.5
2.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
59
819
0.71
1.84
1.2
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
105
810
1.30
1.84
1.9
1.8
g/l
0.2
0.2
0.12
99
771
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
372
3261
1.15
1.83
3.5
2.7
e6/l
1.0
1.0
0.18
230
1757
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
601
5446
1.12
1.79
2.4
2.3
ng/l
375.0
25.5
0.51
322
2177
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
106
824
1.29
1.77
1.9
1.8
g/l
1.1
1.2
5.68
100
784
(3014133) Dog dander IgE Ab [Units/volume] in Serum
65
881
0.73
1.76
1.1
1.1
u/ml
3.9
5.4
0.39
32
402
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
788
0.72
1.75
3.5
4.3
ug/l
10.6
61.0
0.53
43
547
(3017704) Immunofixation for Urine
10
41
2.43
1.74
1.2
1.3
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
6
18
3.32
1.74
7.2
4.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
210
1766
1.20
1.73
1.6
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
46
313
1.47
1.72
1.5
2.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
34
217
1.57
1.71
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
34
217
1.57
1.71
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
60
816
0.73
1.68
1.1
1.1
u/ml
6.8
6.4
0.05
33
385
(3011897) Casein IgE Ab [Units/volume] in Serum
7
161
0.43
1.66
1.3
1.3
—
13.8
—
0
36
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
34
219
1.55
1.65
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
34
219
1.55
1.65
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
222
2579
0.85
1.63
1.7
2.3
nmol/l
15.5
13.0
3.57
186
2330
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
11
49
2.24
1.62
1.1
1.2
—
55.0
—
0
6
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
75
980
0.76
1.62
1.7
1.6
iu/ml
0.0
0.1
1.39
17
200
(3000060) B lymphocytes [#/volume] in Blood
11
223
0.49
1.60
2.4
3.4
e6/l
140.0
254.6
—
6
148
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
21
120
1.75
1.60
4.9
8.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
513
5613
0.89
1.58
3.5
2.8
mmol/l
2.3
2.4
6.79
459
5127
(3021879) Hepatitis B virus core Ab [Presence] in Serum
301
3406
0.87
1.58
1.6
1.5
—
—
—
0
0
(4306422)
33
491
0.67
1.54
1.2
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
121
975
1.25
1.54
1.6
1.5
u/ml
238.6
215.9
0.44
85
570
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
296
0.57
1.53
2.1
3.1
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
44
0.00
1.51
0.0
2.3
—
1.9
—
0
23
(3034770) Mitochondria Ab [Titer] in Serum
95
746
1.28
1.51
1.3
1.5
—
1251.3
—
0
16
(3029937) Albumin [Presence] in Urine by Test strip
620
5686
1.11
1.49
4.2
3.2
estimate
0.0
0.0
0.28
230
2179
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
54
730
0.73
1.49
1.3
1.5
nmol/l
0.4
0.4
0.47
43
614
(3009542) Hematocrit [Volume Fraction] of Blood
2565
26010
0.90
1.45
14.6
10.6
%
39.7
41.1
16.50
2092
22622
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
133
1598
0.82
1.44
1.9
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
617
5668
1.11
1.44
3.9
3.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
11
213
0.51
1.43
1.2
1.1
u/l
0.8
1.0
—
5
81
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
454
4971
0.89
1.42
2.5
2.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
391
3504
1.13
1.42
1.5
1.4
titre
639.4
568.7
0.22
70
583
(3025159) Blasts/100 leukocytes in Blood
183
1552
1.19
1.42
4.2
4.8
%
0.0
0.1
1.80
32
325
(3022217) INR in Platelet poor plasma by Coagulation assay
143
1186
1.21
1.41
4.1
9.4
inr
1.1
1.1
0.08
25
217
(3017181) Myelocytes/100 leukocytes in Blood
197
1683
1.18
1.40
4.2
4.7
%
0.9
0.8
0.07
42
411
(3003327) Ova and parasites identified in Stool by Light microscopy
99
1222
0.80
1.39
1.6
1.8
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
123
1007
1.23
1.38
1.5
1.5
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
25
157
1.59
1.38
1.0
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
28
181
1.55
1.37
1.3
1.1
miu/ml
1301.1
1442.2
0.32
28
181
(3037121) Protein [Mass/volume] in Urine
102
819
1.25
1.37
3.4
5.0
g/l
0.5
0.3
1.06
66
499
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
285
0.59
1.36
1.2
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
124
0.40
1.36
1.2
1.9
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
40
280
1.43
1.35
1.2
1.6
promille
1.4
1.4
0.09
26
216
(3021440) Promyelocytes/100 leukocytes in Blood
189
1616
1.18
1.34
4.2
4.8
%
0.0
0.1
1.72
37
384
(3026389) Candida sp identified in Specimen by Organism specific culture
44
314
1.40
1.34
1.6
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
37
0.00
1.34
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
39
0.00
1.33
0.0
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
30
438
0.68
1.31
1.5
3.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
82
1026
0.79
1.31
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
219
0.54
1.31
4.6
3.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
118
1417
0.82
1.30
1.8
3.4
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
24
2.49
1.29
1.0
1.3
pmol/l
—
5.0
—
0
6
(3022621) pH of Urine by Test strip
143
1199
1.20
1.28
2.8
2.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
147
1725
0.84
1.26
1.8
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
129
1531
0.83
1.26
1.5
1.5
—
—
—
0
0
(44806071)
9
44
2.04
1.26
1.2
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
50
660
0.75
1.22
2.3
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
19
2.62
1.21
2.4
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
140
1642
0.84
1.21
1.1
1.2
au/ml
47.6
41.4
—
6
58
(3017569) Oxygen content in Arterial blood
8
37
2.16
1.21
2.1
4.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
126
1491
0.84
1.20
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
78
969
0.80
1.20
1.7
1.5
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
9
166
0.54
1.18
1.3
3.0
mg/l
9.3
9.7
—
9
138
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
350
3159
1.12
1.16
3.5
2.8
e6/l
3.9
2.8
1.26
205
1657
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
33
0.00
1.16
0.0
1.1
—
—
—
0
0
(3036489) Thrombin time
130
1093
1.19
1.16
2.3
3.8
s
22.0
21.5
0.49
113
957
(3008898) HLA-B27 [Presence]
120
1420
0.84
1.15
1.1
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
126
1484
0.84
1.15
1.4
1.4
—
—
—
0
0
(4198724)
27
390
0.69
1.15
1.5
3.2
—
—
—
0
0
(4027681)
18
283
0.63
1.15
1.2
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
20
2.49
1.14
1.0
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
95
777
1.22
1.12
1.4
1.5
titre
70.0
78.9
—
7
89
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
31
2.25
1.10
1.1
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
535
4951
1.09
1.09
3.8
3.0
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
34
464
0.73
1.06
1.5
1.4
pmol/l
72.5
54.8
0.51
34
451
(3047007) Chlamydophila sp Ab [Presence] in Serum
43
566
0.75
1.06
1.2
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
154
1767
0.86
1.04
2.0
2.2
au/ml
22.2
21.0
—
8
156
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
358
0.69
1.04
1.0
1.0
—
—
—
0
0
(4035726)
107
1264
0.84
1.03
1.4
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
146
0.54
1.03
1.1
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
146
0.54
1.03
1.5
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
147
0.54
1.03
1.1
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
157
1794
0.86
1.01
2.9
3.3
g/l
0.2
0.2
8.23
144
1703
(3006653) Thiamine [Moles/volume] in Blood
5
105
0.47
1.01
1.2
1.5
nmol/l
101.2
138.9
—
5
105
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
89
1066
0.83
1.01
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
77
626
1.23
0.99
3.3
3.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
25
172
1.45
0.98
1.2
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
11
61
1.80
0.97
1.1
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
173
0.57
0.96
1.5
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
29
396
0.73
0.94
1.1
1.2
u/ml
49.4
6.1
0.44
16
144
(3023410) Appearance of Cerebral spinal fluid
27
373
0.72
0.93
2.7
2.9
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
118
0.51
0.93
1.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
6
27
2.22
0.93
6.5
2.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
144
0.55
0.93
1.3
1.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
141
1610
0.87
0.92
1.8
2.0
e9/l
4.5
4.2
0.74
110
1410
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
26
359
0.72
0.90
1.3
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
215
2384
0.89
0.90
3.0
2.3
mmol/l
2.4
2.4
2.71
180
2058
(3020874) Milk IgE Ab [Units/volume] in Serum
29
393
0.73
0.90
1.1
1.2
u/ml
1.1
4.6
1.46
12
172
(3036603) Volume of Urine
18
118
1.52
0.89
2.4
1.6
ml
1452.1
2351.3
—
8
16
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
18
118
1.52
0.89
1.1
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
33
244
1.35
0.89
1.6
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
83
986
0.83
0.89
1.7
1.7
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
9
154
0.58
0.88
2.9
6.5
g/mol
56.4
379.3
—
9
139
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
453
4834
0.92
0.87
2.0
2.2
mg/l
1.1
1.0
0.19
307
3336
(42870588) Differential panel, method unspecified - Blood
783
8183
0.94
0.85
5.7
7.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
262
0.68
0.85
1.9
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
99
841
1.18
0.84
1.8
1.7
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
8
45
1.77
0.84
1.4
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
8
136
0.58
0.83
1.3
2.2
au/ml
—
210.5
—
0
22
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
6
114
0.52
0.82
1.3
1.3
—
33.9
—
0
9
(3028308) Erythrocytes [#/volume] in Pleural fluid
10
57
1.75
0.82
1.1
1.7
e6/l
12822.0
20103.9
—
5
33
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
88
742
1.19
0.82
2.5
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
177
1573
1.13
0.82
3.6
4.3
%
0.4
0.6
0.41
27
309
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
46
1.73
0.82
1.1
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
19
271
0.70
0.81
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
170
1896
0.89
0.81
1.4
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
15
97
1.54
0.80
1.1
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
781
7423
1.06
0.80
7.3
5.5
g/l
35.4
37.9
29.63
732
6972
(42529406) Shigella sp [Presence] in Stool by Culture
66
791
0.83
0.80
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
65
780
0.83
0.79
1.2
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.9
—
12.5
—
0
24
(3007700) Barley IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
1.8
—
0
14
(3007542) Rye IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
1.6
—
0
9
(4268621)
26
349
0.74
0.78
2.4
2.4
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
33
1.81
0.78
1.3
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
33
1.81
0.78
2.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
456
4260
1.08
0.77
3.3
2.5
umol/l
1550.0
2706.1
0.60
415
3915
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
16
233
0.68
0.77
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
41
514
0.79
0.76
1.3
1.9
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
31
234
1.32
0.76
1.4
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
66
785
0.83
0.75
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
10
160
0.62
0.74
1.2
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
18
124
1.45
0.73
2.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
18
124
1.45
0.73
2.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
18
124
1.45
0.73
2.4
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
23
310
0.74
0.73
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
40
498
0.80
0.71
1.5
1.3
u/ml
2.9
5.7
1.15
17
181
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
259
2376
1.09
0.69
3.2
3.4
ng/l
1926.6
542.5
2.11
215
1810
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
90
1034
0.86
0.69
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
16
227
0.70
0.69
2.3
1.3
u/ml
0.5
0.6
—
8
61
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
203
1.33
0.69
1.4
1.8
—
—
—
0
0
(3007916) DNA double strand Ab [Titer] in Serum
5
27
1.85
0.68
1.4
1.7
—
140.4
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
203
0.69
0.68
1.3
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
19
135
1.40
0.67
2.0
2.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
214
2328
0.91
0.67
1.4
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
71
829
0.85
0.67
2.9
3.3
ng/l
295.3
108.3
1.30
62
714
(3045424) Erythrocytes [Presence] in Urine
40
319
1.25
0.67
1.5
1.4
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
95
0.52
0.66
2.0
3.4
ug/l
158.7
131.1
—
5
95
(3037467) Urinalysis macro (dipstick) panel - Urine
1530
15603
0.95
0.66
4.4
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
88
1007
0.87
0.65
1.2
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
326
0.76
0.65
1.1
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
28
214
1.31
0.65
1.2
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
16
224
0.71
0.65
2.1
1.5
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
35
276
1.27
0.65
1.6
1.3
nmol/l
0.4
0.5
0.97
35
268
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
28
359
0.77
0.64
3.1
3.9
u/ml
15.1
80.2
1.36
23
305
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
70
1.57
0.64
6.5
3.7
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
126
0.63
0.64
1.0
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
8
127
0.63
0.64
1.1
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
28
215
1.30
0.63
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
137
1.38
0.63
1.0
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
291
2698
1.08
0.63
3.0
3.4
s
29.0
29.8
2.35
283
2626
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
245
2636
0.92
0.62
2.3
2.5
u/l
7398.2
6232.8
0.24
92
1039
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
101
0.59
0.62
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
42
510
0.82
0.62
1.8
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
138
1.37
0.61
2.2
1.5
mg/l
34.2
24.4
—
6
53
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
14
198
0.70
0.61
1.3
1.4
%
73.1
72.9
0.02
14
188
(3019150) Specific gravity of Urine by Refractometry
520
4929
1.06
0.60
3.7
3.0
kg/l
1.0
1.0
0.92
80
709
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
56
659
0.84
0.60
2.0
2.2
e6/l
43.0
16.4
0.84
45
516
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
21.8
—
0
13
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
45
540
0.83
0.59
1.0
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
56
658
0.84
0.59
2.1
2.2
e6/l
1027.9
5993.7
0.43
49
537
(3028717) Thiamine [Mass/volume] in Blood
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
626
6505
0.95
0.58
2.5
2.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
114
1.40
0.57
2.4
3.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
29
363
0.79
0.57
1.3
1.2
—
—
—
0
0
(4133840)
5
87
0.57
0.56
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
8
55
1.45
0.55
1.6
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
55
1.45
0.55
1.0
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
634
6059
1.05
0.55
5.2
7.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
41
491
0.83
0.54
1.4
1.3
u/ml
5.1
4.3
0.16
21
224
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
14
193
0.72
0.54
1.3
1.4
mu/l
569.5
421.6
0.57
14
183
(3029075) Extractable nuclear Ab panel - Serum
15
107
1.40
0.54
1.1
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
38
1.57
0.54
2.3
6.9
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
38
1.57
0.54
3.7
2.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1260
12245
1.04
0.53
3.8
2.9
ug/l
80.3
79.4
0.08
1187
11632
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
82
1.46
0.53
1.0
2.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
9
63
1.42
0.52
1.1
1.1
—
—
—
0
0
(3019225) pH of Specimen
122
1342
0.90
0.52
6.9
3.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
255
2375
1.08
0.52
1.3
1.2
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
10
145
0.69
0.51
1.1
1.2
—
2.1
—
0
6
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
64
1.40
0.51
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
64
1.40
0.51
1.3
1.4
—
—
—
0
0
(4024509)
17
126
1.35
0.50
1.5
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
43
507
0.84
0.50
1.7
1.9
—
2822.9
—
0
21
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
12
167
0.71
0.50
1.6
2.2
ng/l
148.3
127.2
0.39
12
149
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
155
0.71
0.49
1.6
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
226
2101
1.08
0.49
4.1
3.1
—
—
—
0
0
(44806118)
26
322
0.80
0.49
1.3
1.9
—
—
—
0
0
(44790048)
26
322
0.80
0.49
1.3
1.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
118
1066
1.11
0.48
2.4
4.4
%
95.1
95.6
0.09
112
1005
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(44790049)
26
321
0.81
0.48
1.3
1.9
—
—
—
0
0
(44790047)
26
321
0.81
0.48
1.3
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
121
1323
0.91
0.47
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
573
5931
0.95
0.47
7.4
2.6
u/l
49.9
55.0
1.67
540
5522
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
232
0.77
0.47
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
153
0.72
0.46
2.2
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1143
11116
1.04
0.46
5.3
4.1
estimate
0.0
0.0
0.42
253
2249
(3024980) IgG subclass 4 [Mass/volume] in Serum
43
502
0.85
0.46
1.6
1.8
g/l
0.7
0.7
0.04
30
392
(3001186) Copper [Moles/volume] in Serum or Plasma
5
81
0.61
0.45
3.4
1.5
umol/l
12.7
17.3
—
5
74
(3038026) Centromere Ab [Units/volume] in Serum
8
119
0.67
0.45
1.6
1.3
—
34.5
—
0
10
(3005719) IgG [Mass/volume] in Serum or Plasma
198
2113
0.93
0.45
2.6
2.9
g/l
10.1
10.3
0.32
183
1961
(3044290) Cell count panel - Cerebral spinal fluid
56
639
0.87
0.45
1.9
2.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
7
50
1.40
0.44
2.3
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
43
365
1.18
0.44
1.1
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
34
404
0.84
0.44
1.8
3.6
mu/l
16.1
28.2
3.01
27
386
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
69
775
0.88
0.44
1.5
1.8
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
126
0.71
0.43
1.3
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
591
5683
1.04
0.42
4.2
5.0
inr
1.1
1.1
0.01
208
1931
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
216
2020
1.07
0.42
8.2
2.6
u/l
36.1
63.4
0.57
168
1742
(3014051) Protein [Presence] in Urine by Test strip
47
405
1.16
0.41
2.2
1.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
336
0.83
0.41
1.4
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.1
—
0
5
(3029612) Listeria sp Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
3.6
—
0.4
—
0
15
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
17
131
1.29
0.41
1.4
1.1
%
104.7
89.6
—
7
61
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
33
276
1.19
0.41
1.6
1.3
nmol/l
—
0.5
—
0
9
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
8
59
1.35
0.40
1.1
1.7
u/ml
30.7
6.3
—
8
48
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1148
11195
1.03
0.39
3.9
3.0
estimate
0.0
0.0
1.23
165
2180
(3009871) Measles virus Ab [Titer] in Serum
7
101
0.69
0.39
1.9
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
101
918
1.10
0.39
1.3
1.3
u/ml
0.6
1.2
—
10
71
(3010937) Rubella virus Ab [Presence] in Serum
5
35
1.42
0.39
1.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
995
9684
1.03
0.38
4.6
2.0
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
13
97
1.34
0.38
1.2
1.1
%
105.8
75.7
—
5
20
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
112
0.71
0.37
1.4
2.1
umol/l
15.6
14.6
—
8
112
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
41
470
0.87
0.37
1.1
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
12
89
1.34
0.37
1.2
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
929
9471
0.97
0.37
4.8
5.7
umol/l
10.3
11.2
1.99
874
8880
(40768441) Liver Pathology biopsy report
21
170
1.23
0.36
1.4
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
894
8698
1.03
0.35
3.8
2.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
78
0.64
0.35
1.4
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
79
0.63
0.35
1.4
1.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
6
42
1.42
0.35
1.0
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
11
145
0.75
0.35
1.1
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
24
198
1.21
0.35
1.3
1.2
ratio
1.1
1.1
0.13
11
82
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
22
265
0.83
0.35
1.8
2.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
167
0.77
0.35
1.1
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
124
0.72
0.35
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
50
562
0.88
0.35
1.1
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1138
11120
1.03
0.34
3.9
2.9
estimate
0.0
0.0
1.08
239
2152
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
11
144
0.76
0.34
4.5
4.6
u/ml
433.1
40.9
0.44
11
135
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
73
1.37
0.34
1.1
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
20
242
0.82
0.33
1.2
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
145
1541
0.93
0.33
1.6
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
87
0.69
0.33
1.3
1.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
89
0.67
0.32
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
30
348
0.86
0.32
2.2
2.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
72
652
1.10
0.32
2.2
1.9
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
52
1.34
0.31
1.6
1.5
u/l
20.0
12.8
—
7
52
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
54
1.29
0.30
9.1
5.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
15
120
1.25
0.29
1.9
3.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
15
120
1.25
0.29
1.9
3.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
8
107
0.74
0.29
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
110
0.72
0.28
1.5
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
19
157
1.21
0.28
2.1
2.3
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
17
139
1.22
0.28
1.1
1.1
%
95.3
90.9
—
7
65
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
288
1.14
0.27
1.3
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
260
1.15
0.27
1.4
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
139
0.79
0.27
1.0
1.1
—
5.2
—
0
27
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
98
1043
0.93
0.25
1.4
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
194
1847
1.05
0.25
1.5
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
74
1.21
0.25
3.9
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
74
1.21
0.25
3.9
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
74
1.21
0.25
3.9
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
74
1.21
0.25
3.9
1.9
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
76
815
0.93
0.24
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
587
1.09
0.24
2.3
1.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
9
77
1.16
0.24
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
77
1.16
0.24
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
76
814
0.93
0.24
1.2
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
85
0.70
0.24
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
462
0.90
0.23
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
462
0.90
0.23
1.3
1.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
786
7972
0.98
0.23
2.9
3.5
u/l
29.1
31.1
0.66
744
7612
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
25
284
0.88
0.23
1.1
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
527
5370
0.97
0.22
5.5
4.6
%
95.6
94.1
0.88
513
5244
(3034426) Prothrombin time (PT)
10
124
0.80
0.22
1.5
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
30
335
0.89
0.22
1.8
2.3
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.1
—
570.9
—
0
10
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
7.5
—
0.2
—
0
10
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
366.6
—
0
10
(3023383) Lactate [Moles/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
4.5
—
0
10
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.1
—
42.4
—
0
11
(3022725) Serotonin [Moles/volume] in Serum
0
11
0.00
0.21
0.0
1.8
—
888.5
—
0
11
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
12
0.00
0.21
0.0
7.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
261
0.88
0.21
1.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
104
0.77
0.21
1.5
1.9
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
13
0.00
0.21
0.0
1.2
—
1.7
—
0
13
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
129
1348
0.95
0.20
1.6
1.7
mg/l
3.2
3.8
0.69
119
862
(3014148) Varicella zoster virus Ab [Titer] in Serum
71
661
1.07
0.20
1.3
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
51
1.17
0.19
9.8
5.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
36
393
0.91
0.18
1.3
2.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
156
1616
0.96
0.18
1.3
1.3
miu/ml
247.6
231.6
0.17
58
784
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
59
1.18
0.18
1.0
2.9
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
21
185
1.13
0.17
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
66
0.75
0.17
1.2
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
70
0.71
0.16
1.4
1.5
nmol/l
159.2
87.8
—
5
51
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
281
1.10
0.16
1.8
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
82
1.22
0.16
1.3
1.4
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
10
82
1.22
0.16
1.1
1.1
g/l
—
0.1
—
0
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
171
0.87
0.15
1.2
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
11
129
0.85
0.15
1.0
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1611
16159
0.99
0.15
4.0
3.7
mm/h
9.6
7.4
9.41
1529
15251
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
26
235
1.10
0.15
1.3
1.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
89
0.78
0.14
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
90
0.77
0.14
1.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
36
332
1.08
0.14
1.5
1.4
umol/l
4.5
5.5
1.34
30
303
(4094501)
38
352
1.08
0.13
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
35
323
1.08
0.13
1.9
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
10
84
1.19
0.13
1.3
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
108
0.83
0.13
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
35
324
1.08
0.13
1.3
1.2
—
86.7
—
0
6
(3031040) Bacteria [#/volume] in Urine by Automated count
1427
14311
0.99
0.12
4.2
3.5
e6/l
4356.2
551.5
0.68
33
135
(3024522) Salmonella sp identified in Specimen by Organism specific culture
25
228
1.09
0.12
1.3
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
44
412
1.06
0.12
1.3
1.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
60
568
1.05
0.12
1.5
1.3
u/ml
30.0
9.5
—
8
55
(3025130) Human papilloma virus identified in Specimen
43
455
0.94
0.12
1.8
1.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
22
240
0.91
0.12
1.0
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
25
229
1.09
0.11
1.3
1.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
23
210
1.09
0.11
1.5
1.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
21
191
1.10
0.11
3.1
3.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
51
534
0.95
0.10
3.2
3.8
e9/l
3.2
3.9
3.63
51
534
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
14
156
0.89
0.10
1.0
1.0
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
14
124
1.13
0.10
1.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
228
0.92
0.10
1.1
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
10
86
1.16
0.10
1.0
1.0
mmol/l
19.0
19.6
—
10
80
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
73
699
1.04
0.10
1.2
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
19
207
0.91
0.10
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
25
231
1.08
0.10
1.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
25
231
1.08
0.10
1.3
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
45
1.11
0.09
1.2
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
124
1203
1.03
0.09
1.8
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
16
175
0.91
0.09
4.8
4.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
10
87
1.15
0.09
2.7
1.9
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
144
0.90
0.09
1.7
3.3
u/ml
1330.0
925.8
0.37
13
144
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
25
232
1.07
0.09
1.3
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
2.3
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
54
1.11
0.09
2.3
2.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
55
1.09
0.08
2.3
2.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
23
213
1.08
0.08
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
58
1.03
0.08
1.0
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
5
60
0.83
0.08
1.6
1.5
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
60
0.83
0.08
1.4
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
61
0.82
0.08
1.4
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
65
0.77
0.08
2.6
2.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
136
1.10
0.08
2.6
4.3
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
7
66
1.06
0.08
2.9
3.6
—
20.9
—
0
25
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
8
77
1.03
0.07
1.1
1.5
—
5.9
—
0
10
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
21
195
1.07
0.07
1.1
1.8
%
142.0
115.3
1.29
21
189
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
98
1.12
0.07
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
98
1.12
0.07
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
98
1.12
0.07
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
183
0.92
0.07
2.1
2.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
84
0.83
0.07
2.6
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
9
83
1.08
0.07
1.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
91
0.88
0.06
1.1
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
92
0.87
0.06
1.0
1.1
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
8
93
0.86
0.06
1.4
3.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
11
121
0.91
0.06
1.4
1.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
9
104
0.86
0.06
2.0
1.5
e6/l
115786.7
11703.6
—
9
71
(3051611) Lipemic interference index of Serum or Plasma
23
216
1.06
0.06
4.4
4.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
11
99
1.11
0.06
4.7
4.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
16
148
1.08
0.05
2.3
1.8
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
88
896
0.98
0.05
1.3
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
248
2498
0.99
0.05
3.4
3.8
umol/l
5.5
6.3
0.46
214
2110
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
53
544
0.97
0.05
3.5
4.0
%
51.4
55.2
1.61
53
544
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
23
217
1.06
0.05
1.0
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
675
6686
1.01
0.05
3.3
2.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
29
277
1.04
0.04
1.1
1.1
iu/ml
6.2
6.8
0.09
11
61
(40768443) Skin Pathology biopsy report
70
712
0.98
0.04
1.1
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
163
1607
1.01
0.03
1.6
1.8
g/l
1.3
1.2
0.69
152
1512
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
59
576
1.02
0.03
1.5
1.3
u/ml
2.7
20.5
—
9
81
(3023183) Ammonium ion [Moles/volume] in Plasma
44
448
0.98
0.02
2.0
3.4
umol/l
25.7
33.9
3.17
39
398
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
14
147
0.95
0.02
2.2
2.3
nmol/l
2.6
41.4
0.50
14
138
(40768793) Breast Pathology biopsy report
35
340
1.03
0.02
1.5
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
26
251
1.03
0.02
2.1
1.8
—
—
—
0
0
(4211845)
11
103
1.06
0.01
2.5
2.0
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
24
232
1.03
0.01
1.6
1.3
—
30.2
—
0
6
(3021788) Differential panel - Synovial fluid
25
256
0.97
0.01
2.1
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
206
0.97
0.01
1.2
1.1
—
—
—
0
0
(4281824)
10
106
0.94
0.01
1.2
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
33
322
1.02
0.01
1.3
1.3
g/l
6.3
6.5
0.12
23
234
(3024139) IgG subclass 3 [Mass/volume] in Serum
33
322
1.02
0.01
1.3
1.3
g/l
0.4
0.4
0.02
23
233
(3028192) IgG subclass 2 [Mass/volume] in Serum
33
323
1.02
0.00
1.3
1.3
g/l
2.9
2.7
0.24
23
236
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
104
1.05
0.00
1.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
23
232
0.99
0.00
1.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
177
1.01
0.00
1.3
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
112
0.98
0.00
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
21
210
1.00
0.00
1.5
1.3
—
—
—
0
0
(4062490)
32
324
0.98
0.00
1.3
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
26
264
0.98
0.00
1.2
1.2
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
11
107
1.02
0.00
1.0
1.1
—
5.0
—
0
10
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
290
2887
1.00
0.00
3.2
2.9
ng/l
786.5
620.4
0.16
157
1489
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
33
327
1.01
0.00
1.2
1.2
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
53
531
0.99
0.00
1.4
1.3
u/ml
6.8
34.4
—
8
41
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
63
631
0.99
0.00
1.4
1.3
u/ml
26.4
32.6
—
5
38
(44813793)
26
262
0.99
0.00
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
179
1.00
0.00
1.2
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
92
919
1.00
0.00
2.7
2.1
u/l
44.2
39.9
1.05
81
865
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
53
532
0.99
0.00
1.7
1.6
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
3.2
—
140.2
—
0
9
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
67
0.89
0.00
1.0
1.1
—
—
—
0
0
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
0
9
0.00
0.00
0.0
1.1
—
195.2
—
0
9
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
8
0.00
0.00
0.0
1.0
—
8.9
—
0
8
(3043410) Blood group antigens tested for on Red Blood Cells
6
69
0.87
0.00
3.8
1.3
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
59
1.01
0.00
3.0
6.3
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
49
1.02
0.00
1.2
1.1
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
7
71
0.98
0.00
2.0
2.6
ug/g
162.4
178.5
—
7
66
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
7
0.00
0.00
0.0
8.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
75
0.93
0.00
4.3
5.6
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
74
0.94
0.00
2.7
1.5
ug/l
11.3
8.5
—
7
74
(3041184) Isoniazid [Presence] in Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
14.0
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
6.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
89
0.90
0.00
1.1
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
77.8
—
0
5
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
52
0.96
0.00
1.2
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
61
0.98
0.00
3.0
6.3
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
2.0
—
687.3
—
0
5
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
8.8
—
0
6
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
125.3
—
0
5
(4038314)
8
84
0.95
0.00
1.3
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
7.2
—
5.7
—
0
5
(3012441) Differential panel - Pleural fluid
6
66
0.91
0.00
1.0
1.6
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
17.5
—
0
7
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3013931) Oligosaccharides [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: T1D_EARLY – Type1 diabetes, definitions combined, early onset

GWS hits: 22

This endpoint is excluded (different definition than used in FinnGen).